ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, DCLRE1A, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, MUM1, CIB1, BRCA1, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, RFC5, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, NCOA6, PARP2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PCNA, PNKP, COPS7A, UNG, RAD51AP1, TFPT, FZR1, WRN, POLR2B, RAD21, RAD54L, POLR2G, USP51, FANCI, POLQ, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, FANCE, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, UBE2T, POLE2, CDK2, ERCC5, MNAT1]
GO:1900370;positive regulation of RNA interference;9.0;0.9326813400603323;0.8625812952104552;9.55953138100517;124.83038160076495;9.777073627680469;0.004177960532127896;0.896240625180289;[XPO5]
GO:0015793;glycerol transport;7.0;1.0;0.8509193652572005;9.628524252492122;38.31975435487899;7.9853141584524145;0.0012825276927178712;0.7592887026755414;[AQP3, AQP1]
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[POLB, SMUG1, USP36, POLQ, NEIL3, WRN, PARP2, APEX2, UNG]
GO:0015671;oxygen transport;5.0;1.0;0.7902410118609202;9.628524252492122;26.519296615914115;7.138016298065211;8.875769919171911E-4;0.6552794972956795;[MYC]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[RFC5, AQR, RFC3, RFC4, PCNA, CCNH, COPS7A, GTF2H4, DDB1, COPS5, POLR2B, EP300, POLR2G, ERCC5, MNAT1]
GO:0009312;oligosaccharide biosynthetic process;5.0;0.6997970393407541;0.6401395315312973;8.606873004960141;68.90401286392341;6.832634648514029;0.0023061553009699424;0.639662265535933;[FUT8]
GO:0035281;pre-miRNA export from nucleus;9.0;1.0;0.896240625180289;9.628524252492122;78.87128377692001;9.083926447120524;0.002639750888466496;0.8607930461318132;[XPO5]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[RFC5, RFC3, WRN, NPLOC4, RFC4, PCNA, POLE2, WRNIP1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, SPHK1, ITGB2, CIB1, NLRC4, NFKB1, RELA, MTDH, RPS6KA4, TRIM14, NLRP3, RIPK1, KRAS, TRIM32, CARD11]
GO:0071380;cellular response to prostaglandin E stimulus;8.0;1.0;0.875;9.628524252492122;704.3614414198233;6.943860283624253;0.023574343560179453;0.7301093378270707;[SFRP1, GNG2, ACACA]
GO:0006169;adenosine salvage;11.0;1.0;0.9324289523296623;9.628524252492122;7214.944699533855;9.777073627680469;0.24147770606473165;0.9324289523296623;[ADK]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[AGPAT5, SFRP1, COL24A1, XRCC5, HOXB4]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[MAP3K3, XBP1, SPHK1, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, PDCL3, RRAS, SP1, TBXA2R, CTSH, EPHA1]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[KLF13, CDK6, ARNT, NCKAP1L]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ENDOG, ELL, UBE2B, RIC8A, FLCN, CCNB1, FUT8, RXRA, ALS2, MAFF, CCM2, SOX8, EIF4E2, ATP7A, APBA3, SOX6, SEC24C]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, ZNF175, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, MYC, ZXDC, DPF2, TRIM24, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, NOLC1, RLF, SUPT6H, HSPH1, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, WDR43, CKS1B, FLCN, NIPBL, LBH, NUP62, HRAS, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIA, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1]
GO:2000234;positive regulation of rRNA processing;8.0;1.0;0.875;9.628524252492122;509.0927097605666;7.57984905034425;0.017038874841993235;0.7626338329336335;[WDR43]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, UPF1, FEN1, RFC3, RFC4, PCNA]
GO:0018279;protein N-linked glycosylation via asparagine;9.0;0.8653626801206646;0.8289219652406215;9.4949928598676;334.83267440717236;6.113511981550823;0.011206548282565083;0.7088859122241795;[ST6GAL1, FUT8, DERL3, RPN1, SYVN1, STT3A]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[TBX1, XBP1, WDR48, ITGB3, ARNT, NME1, PDCL3, SFRP1, SP1, CCL5, MYC, ATP7A, HRAS]
GO:0032204;regulation of telomere maintenance;7.0;0.6519675769143192;0.6769031537143602;8.969278623607858;103.7409614847858;5.395046993006588;0.003472116620091941;0.6268223193749;[UPF1, SMG1, GNL3L, XRN1, XRCC5, PNKP, MYC, NAT10, SMG5, DCP2]
GO:0044209;AMP salvage;12.0;1.0;0.9481203125901445;9.628524252492122;9053.48655874345;9.083926447120524;0.303012047512228;0.9126727335416687;[ADK]
GO:0036245;cellular response to menadione;6.0;1.0;0.8231203125901445;9.628524252492122;172.216525716168;9.083926447120524;0.005763932130909465;0.7876727335416686;[DCPS]
GO:0006054;N-acetylneuraminate metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;88.37267973599849;7.379178354882098;0.002957754060515648;0.7004918368257019;[ST6GAL1]
GO:0034067;protein localization to Golgi apparatus;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;32.77360880529348;6.686031174322154;0.001096903192380182;0.665044257777226;[GAK, PAQR3, RAB6A]
GO:0006175;dATP biosynthetic process;12.0;0.9326813400603323;0.9144609826203107;9.610505746989444;6413.462164351743;9.777073627680469;0.2146528068996381;0.9481203125901445;[ADK]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[CDK5, FES, HRAS]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[DDB1, RFC5, RFC3, RFC4, PCNA, ERCC5, GTF2H4]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[DDB1, CCNH, ERCC5, MNAT1, GTF2H4]
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1106.254199480119;7.9853141584524145;0.03702533249245755;0.8236103492792612;[RFC5, RFC3, RFC4]
GO:0043112;receptor metabolic process;5.0;0.6519675769143192;0.6162248003180799;8.278597535543106;33.00951817117477;5.171903441692378;0.0011047988665515837;0.5547323943871747;[BECN1, ARFGEF2, FCER1G, CAMLG, TFRC, ITGB2, CLTA, FUT8, ALS2, SYNJ1, CDK5, SNX25, AP2S1, CD9, PLEKHJ1]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[RAB3B, NCKAP1, CDKN1A, ROCK2, RASGRP2, RAB21, RAB43, RAP1B, RHOT2, RHOT1, RAB20, RRAS, ARHGDIB, CFL1, RAB28, RAB6A, HRAS, RAB8B, KSR1, SETDB1, RAB27B, RAB11A, NISCH, COL1A2, ALS2, RAB13, CDK2, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, KPNB1]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, RFC4, PCNA]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, MSH3, EXO1]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[DCLRE1A, DCLRE1C, CCNH, MUM1, CIB1, YY1, MYC, EP300, NEK1, GTSE1, AQR, TIPIN, FBXO18, NSMCE2, NEIL3, MSH3, DDIT4, TIMELESS, COPS7A, RAD51AP1, NUAK1, CCNB1, RAD21, USP51, FANCI, UBE2B, XRCC5, INTS3, NONO, CNOT10, CDC7, FANCE, SETX, CDK9, CNOT4, CNOT6, COPS5, NPLOC4, CNOT1, UBE2T, BCL3, CNOT3, CDK2, INTS7, CNOT8, MNAT1, USP36, FEN1, BTG2, CDKN1A, SMG1, WDR48, MCM10, BRCA1, AATF, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, CASP2, CTLA4, TOPBP1, RFC5, UPF1, RFC3, RFC4, DTX3L, NCOA6, PARP2, RAD23A, TFIP11, MASTL, DDB1, RAD51C, TFDP1, TFDP2, PCNA, PNKP, TANK, UNG, TFPT, FZR1, WRN, POLR2B, RBBP5, RAD54L, POLR2G, BID, E2F7, E2F8, POLQ, EYA2, GINS4, DONSON, APEX2, GTF2H4, SMUG1, HIST3H2A, RAD51, POLE2, TAOK2, MNDA, ERCC5]
GO:0006853;carnitine shuttle;11.0;1.0;0.9324289523296623;9.628524252492122;360.1106399154393;7.697632086000634;0.01205257903943479;0.8260862151842345;[CPT2, SLC25A20, ACACA]
GO:0006611;protein export from nucleus;9.0;0.7508913569872202;0.7716863036738992;9.277126365654233;128.4390295807893;5.948432231191374;0.00429873873244698;0.7004437261138039;[RPS15, AHCYL1, NUP62, XPO5]
GO:1900029;positive regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;7.138016298065211;0.006704083591926775;0.7612791106150483;[FAM98A, HRAS]
GO:0045656;negative regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;842.1281654798506;7.8311634786251565;0.028185271832466503;0.7967266896635242;[CDK6, MYC]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[FANCI, TIPIN, TAOK2, CDK2, DONSON, INTS7, TOPBP1]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[CDKN1A, WRN, XRCC5, ELK1, HRAS]
GO:0045540;regulation of cholesterol biosynthetic process;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;116.98845768213258;6.039404009397101;0.0039154983958446;0.705096027081865;[SQLE, GPAM, SP1, NFYC, SCAP, ELOVL6, ERLIN2, KPNB1, ACACA]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[SFRP1, CDK6, PLEKHA2, CIB1, EPHA1, LIMS1]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[CDKN1C, SFRP1, CDK6, NFIB, ATPIF1, EAF2, IFT122, THBS1]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[ACTR2, ARPC2, ROCK2, ARPC1A, AP2S1, EPHA1, EFNA4, HRAS]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[UPF2, NFKBIA, PRPS2, CDKN1A, PCNA, PPAT, CAD, LCP1, RPL19, EZH2]
GO:0071800;podosome assembly;5.0;1.0;0.7902410118609202;9.628524252492122;81.13164658075348;7.697632086000634;0.00271540319731635;0.6838982747154925;[NCF1, SH3PXD2A]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[RAB3B, TRAM1, SYS1, RPL3, NCF1, ITGB2, SRP54, BUB1B, ZDHHC6, ABCA12, TRAM2, IPO4, RPS15, NIPBL, IPO8, NUP62, TMEM107, LAMP2, TMED2, LONP2, TNPO1, TNPO2, RAB8B, GSTK1, GRIPAP1, RPS9, SEC13, FCER1G, RPS7, SSR2, COG3, PAQR3, ARMCX3, GAK, ACOX2, AGPS, CHMP4B, EXOC3, PIK3C3, MAPRE1, RPL29, VAMP5, SLC27A2, KPNB1, ACOT4, EXOC1, MCPH1, BECN1, SEH1L, ROCK2, ZDHHC23, HSD17B4, ZDHHC24, RGPD1, TM9SF4, FBLN5, AP3M1, UGT8, WRN, RAD21, LMNA, HEATR3, BID, RAB6A, FAM83D, RAE1, RPL19, PEX16, BBS2, TIMM8B, UBL4A, SEPT11, TMEM30A, PEX19, TOR1A, PMM1, XRCC5, RAB3IP, IFT122, NUP153, RPL23A, TIMM44, RAB11A, SPCS2, CDK5, GOLGB1, SLMAP, VPS41, TSPAN17, RAB13, TAOK2, RAB3GAP2, DCP1A, RAB3GAP1, EZH2]
GO:1902570;protein localization to nucleolus;7.0;1.0;0.8509193652572005;9.628524252492122;34.85305034697331;7.8311634786251565;0.0011665002294043187;0.7514054297404357;[WRN]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[CDK5, ITGB2, CIB1, HRAS]
GO:0000959;mitochondrial RNA metabolic process;7.0;0.6144040707577935;0.6581214006360973;8.36628254004221;115.0816327851482;6.113511981550823;0.0038516786825735262;0.663564652301091;[FASTKD1, PUS1, FASTKD5, EARS2]
GO:1900034;regulation of cellular response to heat;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;29.43425144606613;5.970411137910149;9.851379067933503E-4;0.6284474158353811;[CREBBP, HSPH1, DNAJC7, BAG3, BAG1, EP300, IER5]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[FEN1, PNKP, MCM10, BRCA1, POLB, CHAF1B, WRN, CHAF1A, EXO1, RFC5, UPF1, POLQ, RRM1, RFC3, DUT, RFC4, NCOA6, DONSON, WRNIP1, CDC7, BAZ1A, NFIA, NFIB, NFIC, POLE2, CDK2, CDK2AP1, MCM5, MCM6, MCM2]
GO:0000956;nuclear-transcribed mRNA catabolic process;9.0;0.6873818243518346;0.7399315373562063;9.295818498666385;714.7700062418027;4.519578255652688;0.023922708857670925;0.6273720673562503;[HBS1L, SMG1, RPL3, EIF4A3, CASC3, SMG5, PPP2CA, RPS15, POLR2G, EXOSC3, DCPS, RPL19, UPF2, UPF1, RPS9, RPS7, CNOT10, RPL23A, LSM5, CNOT4, CNOT6, PAN3, XRN1, CNOT1, CNOT3, MRTO4, SKIV2L, ETF1, CNOT8, DCP1A, RPL29, DCP2]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[POLB, RFC5, POLQ, RFC3, RFC4, POLE2, PNKP, DONSON, CDK2AP1, WRNIP1, BAZ1A]
GO:0043928;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;11.0;0.9326813400603323;0.8987696223598284;9.60383163990175;718.8643508040237;6.280566066213989;0.024059742885497587;0.7536173930320365;[HBS1L, CNOT6, SKIV2L, CNOT8, LSM5, DCP1A, EXOSC3, DCPS, DCP2]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[FCER1G, LCP2, CALM1, NFKB1, VAV1, RELA, CARD11]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, UBE2I, SLC20A1, ZDHHC13, RELA, MTDH, AKAP13, CD4, TFG, TNIP2, UBD, NUP62, RIPK1, CCL19, ECT2, TRIM32, CARD11, TMED4]
GO:0006024;glycosaminoglycan biosynthetic process;6.0;0.7586651285174919;0.7024528768488905;9.158520623246385;237.49504005673018;5.16195311083921;0.007948745259039342;0.5871028347338303;[PDGFRB, UGDH, CHPF, CHST12, ABCC5, SLC35D2, SDC1, B4GALT7]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[NCKAP1, C12orf57, TRAK1, UGT8, WEE1, LRFN4, SLC9A6, ALS2, CDK5, NFIB, TAOK2, NCKAP1L, NPTX1, ATP7A, NEFH, PAFAH1B1, ZNF365]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, RFC4, PCNA, POLE2]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, PPAT, CAD, ATP7A, USF2, NME1]
GO:0097193;intrinsic apoptotic signaling pathway;6.0;0.7436939687323844;0.6949672969563367;9.0689084645567;50.98493142520191;4.74012102526684;0.0017064197713422317;0.5655303222604612;[CDKN1A, XBP1, DIABLO, BRCA1, KRCC1, BBC3, ERN1, POLB, ZMAT1, PERP, BCL3, DDIT4, ARL6IP5, TP53BP2, CASP2, EP300, ZNF622, HRAS]
GO:0006029;proteoglycan metabolic process;6.0;0.7140352122741334;0.6801379187272112;9.057979394024509;96.66964063832829;5.825829909099042;0.0032354458751365986;0.6210535250702663;[EXTL2, CYTL1, B4GALT7]
GO:0002101;tRNA wobble cytosine modification;12.0;0.8933024483968273;0.8947715367885583;9.548481544818586;495.6768096603374;8.67846133901236;0.016589856739164775;0.8919372290569614;[NAT10]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CREBBP, FCER1G, EP300, KRAS, HRAS, NFKB1, RELA, CARD11]
GO:0045668;negative regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;170.3268387162597;6.015873511986907;0.0057006860076304205;0.6307723637598831;[SFRP1, TWSG1, CDK6, IGFBP5]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL4R, IRF4, BCL3, IL12A, LYST, HRAS]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGRP4, PABPN1, CCL5, MYC, CTSH, NCAM1, MBP, RIPK1, HRAS, PDGFRB, MAP3K3, DUSP5, KSR1, PAQR3, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, CCM2, KRAS, CALM1, HBEGF]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[FUT8, FCER1G, ITGB4, ITGB3, ITGA2, ITGB2, NEDD9, CCM2, VAV1]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, ENDOG, CPNE2, ECT2, ARID1A, RASGRP2, TUBG1]
GO:0072488;ammonium transmembrane transport;7.0;0.7763722522362496;0.7391054913753253;9.193206181234276;79.759283350777;7.069023426578259;0.002669471435055758;0.7124295520356204;[SLC12A2, SLC25A20, RHD, AQP1]
GO:0048147;negative regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;6.409777797693995;0.0021377902344145586;0.6509166472493662;[SFRP1, MYC, TP53INP1, TRIM32, B4GALT7]
GO:0051782;negative regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.39638057119949;42.45111992378225;7.004484905440688;0.0014208007803214436;0.6484506956670166;[MYC, E2F7, E2F8]
GO:0051661;maintenance of centrosome location;6.0;1.0;0.8231203125901445;9.628524252492122;46.01609631687506;7.9853141584524145;0.0015401173319278046;0.7314896500084853;[TBCCD1, PAFAH1B1]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[CIITA, CDKN1A, CD80, ITGB2, IL5RA, CIB1, RORA, IL27, RPS6KA4, MYC, CFL1, IL12A, CCR2, HLA-DPA1, IFNAR2, IL4R, FLT3LG, HLA-A, HLA-F, YWHAZ, VAV1, KARS, IL23A, IRF4, PSME2, LCP1, EBI3, LRP8, ADIPOR2, RELA, IL22RA2, HSP90B1, RAP1B, CCL5, IL21R, NCAM1, RIPK1, CCL19, HLA-DQA1, BBS2, MAP3K3, CCL20, CD70, TNFRSF10A, NFKB1, NFKBIA, CD4, IL6, COL1A2, TNIP2, HLA-DPB1, SDC1, KRAS, HLA-DRB3, LIMS1]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[PDGFRB, CDKN1A, CCNB1, CDK6, SPHK1, MYC, FNTB, AQP1]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[SEPT11, PDCD6IP, KIF23, CIT, SPAST, SON, ESPL1, KIF4A, CFL1, JTB, CHMP4B, KIF20A, ECT2]
GO:0032543;mitochondrial translation;8.0;1.0;0.875;9.628524252492122;403.65714686199146;6.193554689224359;0.013510041437624024;0.6917386748366816;[NDUFA7, MRPS24, MRPS18B, MRPS18A]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[BTG2, CDKN1A, PCNA, CNOT10, CNOT4, CNOT6, CCNB1, TFDP1, RBL1, TFDP2, CNOT1, CTDSP2, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8, DACT1, EZH2]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, NPLOC4, RFC4, PCNA]
GO:0046081;dUTP catabolic process;12.0;1.0;0.9481203125901445;9.628524252492122;7784.425485326349;9.083926447120524;0.26053771546577353;0.9126727335416687;[DUT]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[CCNE2, CCNE1, GINS4, MCM10, CDC7, MCM5, TOPBP1, MCM6, MCM2]
GO:0007000;nucleolus organization;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;20.915744831851537;7.8311634786251565;7.000311565738116E-4;0.6907270763441554;[USP36, NOLC1]
GO:0006272;leading strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;8.67846133901236;0.008899953129253659;0.8400575416471059;[PCNA]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[POLQ, FEN1, WDR48, FBXO18, GINS4, NSMCE2, CDC7, BRCA1, YY1, RAD51AP1, NIPBL, WRN, RAD51C, RAD51, RAD54L]
GO:0045795;positive regulation of cell volume;7.0;1.0;0.8509193652572005;9.628524252492122;50.63290440139966;9.777073627680469;0.001694637743659323;0.8509193652572005;[SLC12A2]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[ROCK2, TANK, NFKB1, RELA, NFKBIA, IRAK1BP1, NKIRAS1, TNIP2, TIFA, BCL3, SNIP1, RIPK1, CARD11]
GO:0003323;type B pancreatic cell development;7.0;1.0;0.8509193652572005;9.628524252492122;37.346163459204256;7.379178354882098;0.001249942481614558;0.728290889492758;[CDK6]
GO:0000288;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;10.0;1.0;0.9152410118609203;9.628524252492122;717.2549128915896;7.292166977892469;0.0240058764469685;0.7881627702307852;[CNOT4, CNOT1, CNOT3, DCPS]
GO:0070295;renal water absorption;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;39.39707145230216;8.67846133901236;0.0013185845264461838;0.7947362817240173;[AQP3]
GO:0072355;histone H3-T3 phosphorylation;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;710.1813063381824;9.083926447120524;0.02376912920145855;0.8969813732811862;[VRK1]
GO:0070970;interleukin-2 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;8.67846133901236;0.004587596526932657;0.8590579283277371;[GPAM, CARD11]
GO:0097510;base-excision repair, AP site formation via deaminated base removal;8.0;1.0;0.875;9.628524252492122;150.14073953485922;9.777073627680469;0.005025075434338753;0.875;[UNG]
GO:0000290;deadenylation-dependent decapping of nuclear-transcribed mRNA;10.0;1.0;0.9152410118609203;9.628524252492122;717.2549128915896;7.474488534686424;0.0240058764469685;0.7974867031240476;[PAN3, DCP1A, DCPS, DCP2]
GO:2000145;regulation of cell motility;5.0;0.46812423412493653;0.5243031289233886;6.883086519318291;34.54403569627484;3.0677692874221707;0.001156157787140571;0.44712687588555144;[MCTP1, ONECUT2, DOCK8, ITGB3, KIF14, CIB1, DEFB1, IGF1R, FLCN, NIPBL, ADORA3, C1QBP, ARHGDIB, CTSH, IL12A, ATP7A, GTSE1, HRAS, CCR2, SEMA6B, PDGFRB, TBCCD1, IGFBP5, ITGA2, SPHK1, PTP4A1, BCR, NISCH, CREB3, SFRP1, KARS, IL23A, RUFY3, EPHA1, MAPRE1, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, ABR, RRAS, TBXA2R, CCL5, TP53INP1, LMNA, NCKAP1L, LRIG2, CCL19, RFFL, MTA2, CLASP1, BBS2, RNF20, MAP3K3, STARD13, XBP1, CCL20, IDH2, RAB11A, VIL1, IL6, P2RX4, CDK6, CDK5, SP1, FES, TRIM32]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[PDCL3, SP1, ITGB3, ARNT]
GO:0031325;positive regulation of cellular metabolic process;5.0;0.33430305599673393;0.45739253985928724;5.38799718009194;79.98476956498574;1.7414709347618875;0.0026770182557209064;0.37929991645132366;[ZNF175, TFRC, MAML1, CCNH, GFI1, EIF4A3, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, RPS6KA4, MYC, ZXDC, DPF2, TRIM24, ARL6IP5, SOX8, IL12A, SKP2, SOX6, IER5, IER2, ENDOG, FLT3LG, MAPK8IP3, MED6, RUNX2, SFRP1, TWSG1, KARS, IL23A, RFX4, HOXB4, JTB, PSME2, EPHA1, CDCA2, EBI3, NOLC1, ZC3HAV1, MTDH, C3, FXR1, HSPH1, RAD21, HLTF, VPS11, SCAP, HOXC4, NCKAP1L, NTSR1, ZNF143, CREBBP, PRELID1, XBP1, SETDB1, XRCC5, EDEM1, PBX3, EIF2AK3, EAF2, PILRB, CDC7, ERLIN2, FLI1, SETX, STAG1, CALM3, CALM1, CALM2, EZH2, CDKN1C, BTG2, CDKN1A, WDR48, SETD3, ELL, ZFAND2A, KIF14, IL27, HOXC13, BRCA1, AATF, WDR43, BBC3, AKAP13, NIPBL, C1QBP, CTSH, HRAS, CCR2, HAVCR2, ZNF485, UPF1, DUSP5, SEC13, NCOA6, ELOVL5, SPHK1, ATPIF1, TMEM173, PPRC1, GFRA2, SIRT2, GAL, MTF2, TFEC, ARHGEF5, HBEGF, ZNF350, PCNA, TANK, RELA, ARNTL, UNG, PPP2CA, SERTAD3, BCLAF1, WRN, RXRA, SERTAD2, PPP1R7, PERP, GPBP1L1, CCL19, BID, EXOSC3, ZNF462, MAP3K3, YTHDF3, CCL20, NFYC, ATAD2, GPR55, GRHL1, CENPE, ITCH, NLRP12, NFIA, NFIB, NFIC, CAMK4, MARS, PSMC1, TAOK2, RAB3GAP2, CAMK1, RAB3GAP1, CRTC2, NCF1, CD80, ARID4A, CIB1, RORA, COMT, IGF1R, YY1, EP300, NEK1, ZNF564, PDGFRB, RPS9, FBXO18, PIAS2, ERN1, ARMCX3, ACLY, ILF3, BRMS1, TBL1XR1, CCNE1, TIMELESS, ADNP, CARD11, DIABLO, MAX, CLEC16A, RLF, SUPT6H, ACACA, STK3, RAP1B, CCNB1, DVL3, NLRP3, MBP, RIPK1, CYTL1, ECT2, MARK2, BPTF, FANCI, TFAP2A, ZBTB17, DR1, UBE2I, UBE2B, WFS1, RHBDD1, GLMN, TNFRSF10A, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, CNOT8, MNAT1, NFE2L1, PHF19, BCAR3, CIITA, ONECUT2, CALCOCO2, ITGB3, ITGB2, PTPN22, DDX41, CKS1B, FLCN, LBH, NUP62, DACT1, RFC5, FGA, RFC3, TBP, KLF13, RFC4, KSR1, PEG3, DTX3L, ITGA2, FGG, MKL1, PLAUR, ZFP91, ARNT, RAD23A, PPP2R5D, OXSR1, SENP2, SAFB, ARID1A, MASTL, DUSP22, CREB3, TFDP1, RBL1, ALS2, TFDP2, ELF4, IRF4, LCP2, BECN1, VAC14, HDAC3, HDAC1, WBP2, ROCK2, POLDIP3, PNKP, ITLN1, NLRC4, LRP8, THBS1, CLEC3B, FZR1, U2AF2, TP53INP2, CCL5, TP53INP1, UBQLN1, POLR2G, CSK, ZNF622, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, PDE6H, EYA2, ARID3B, HSPE1, USF2, TSHR, CD4, RAD51, P2RX4, TNIP2, TAF7, CDK2AP1, PTX3, KRAS, TRIM32, CD244]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, CDKN1A, CDKN2C, THBS1, PRKAB1, PPM1G, ERN1, CDK6, FAP, MYC, TP53INP1, IL12A, PRR11, HRAS, EIF4G2, MCPH1]
GO:0043549;regulation of kinase activity;8.0;0.5318528234273745;0.6409264117136872;7.75672207559053;45.50531354295741;2.9903566770753884;0.0015230218921594328;0.5279269795314422;[CDKN1C, ERRFI1, CDKN1A, NCF1, CCNH, ITGB3, CCNF, KIF14, CIB1, PTPN22, DUSP14, IGF1R, CKS1B, AKAP13, NUP62, NEK1, HRAS, PDGFRB, DUSP5, KSR1, PAQR3, ZFP91, OXSR1, MAPK8IP3, CDC25A, ERN1, DUSP22, SFRP1, RBL1, KARS, ALS2, CCNE2, IL23A, CCNE1, JTB, LCP2, ADNP, EPHA1, CHMP6, ARHGEF5, MCPH1, VAC14, PKMYT1, LRP8, THBS1, STK3, PPP2CA, CCNB1, HSPH1, CCL5, STK38, DVL3, NCKAP1L, RIPK1, CSK, ZNF622, CCL19, ECT2, MARK2, MAP3K3, CDKN2C, PDE6H, XRCC5, TNFRSF10A, PILRB, CENPE, CD4, CDK6, PIK3IP1, CDK5, GNAQ, PKIA, TAOK2, TAF7, KRAS, CALM3, CRIPAK, CAMK1, CALM1, MNAT1, CALM2, CCNJL, EZH2]
GO:0016447;somatic recombination of immunoglobulin gene segments;10.0;0.7436939687323844;0.7870879962271125;9.318369324188282;172.3391926387256;6.686031174322154;0.005768037682414404;0.7571649570480019;[POLB, MSH3, EXO1, EXOSC3, UNG]
GO:0090656;t-circle formation;8.0;1.0;0.875;9.628524252492122;168.69220570471313;7.379178354882098;0.005645976311808157;0.7523715242355574;[WRN, EXO1]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, SUPT6H, EFTUD2, PPP2CA, UBL5, PABPN1, PCF11, U2AF2, POLR2B, C1QBP, ARL6IP4, DHX16, SNRPB2, POLR2G, ZNF326, SMNDC1, DCPS, RBM5, AQR, PRPF38A, GPKOW, WTAP, BUD31, CPSF3, NONO, CPSF2, TFIP11, THOC2, LSM5, SRRM1, THOC6, ERN1, SON, PSPC1, PRPF3, SNRPG, CD2BP2, ACIN1, SLU7]
GO:0034551;mitochondrial respiratory chain complex III assembly;8.0;1.0;0.875;9.628524252492122;92.36633852809379;7.57984905034425;0.003091418226227511;0.7626338329336335;[BCS1L]
GO:0090650;cellular response to oxygen-glucose deprivation;6.0;1.0;0.8231203125901445;9.628524252492122;135.19734744625808;7.8311634786251565;0.004524933549313023;0.7236063770733796;[AQP3]
GO:0006084;acetyl-CoA metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.807543700422292;79.28961856538737;6.409777797693995;0.002653752177359632;0.6509166472493662;[ACLY, ACACA]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[HSPH1, NCF1, CCL5, LRP8]
GO:1902990;mitotic telomere maintenance via semi-conservative replication;9.0;1.0;0.896240625180289;9.628524252492122;232.51800064843582;8.67846133901236;0.007782168229088393;0.8400575416471059;[PCNA]
GO:0036297;interstrand cross-link repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;5.905872616772578;0.006126539929698291;0.6770266002729131;[RAD51AP1, FANCI, DCLRE1A, DCLRE1C, RAD51, UBE2T, FANCE]
GO:0009116;nucleoside metabolic process;6.0;0.5127202928476964;0.5794804590139927;8.04289698875174;148.96441490805535;4.948759890378168;0.00498570490770306;0.5762001235249539;[PRPS2, AHCYL1, APOBEC3F, APOBEC3H, AMD1, CAD, ADK, NME1, PDCL3, UCK2, IMPDH2, PPAT, PDE6B, APOBEC3A, CARD11, TJP2]
GO:1902512;positive regulation of apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;902.4454322749122;8.67846133901236;0.030204036470081387;0.8400575416471059;[ENDOG]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[DUSP22, TWSG1, FUT8, COL1A2]
GO:1904812;rRNA acetylation involved in maturation of SSU-rRNA;12.0;1.0;0.9481203125901445;9.628524252492122;626.5528723061163;9.777073627680469;0.020970160775109593;0.9481203125901445;[NAT10]
GO:1901300;positive regulation of hydrogen peroxide-mediated programmed cell death;10.0;0.9326813400603323;0.8815816818910864;9.59462270081644;687.1203596772255;8.390779266560578;0.022997300070220886;0.8443458537639685;[ENDOG]
GO:0090096;positive regulation of metanephric cap mesenchymal cell proliferation;8.0;1.0;0.875;9.628524252492122;513.686511472305;9.777073627680469;0.017192625251131993;0.875;[MYC]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[RRM1, SEPT11, CPSF6, COL1A2, YWHAB, NUP62, RIPK1, IKZF1, HSD17B8, PRKAB1, HRAS]
GO:0009113;purine nucleobase biosynthetic process;8.0;0.7763722522362496;0.7631861261181248;9.474373572664863;934.1877806379209;7.138016298065211;0.03126642430353244;0.7400384854347593;[MTHFD1L, MTHFD1, PPAT]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, RABGAP1, DOCK8, RASGRP2, RIC8A, ABR, DOCK11, ARHGAP21, RGS1, CCL5, ARHGDIB, DVL3, NCKAP1L, EVI5L, CCL19, ECT2, A2M, TBC1D22A, HRAS, STARD13, SEC13, CCL20, TBC1D8, TBC1D2B, ARHGAP25, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, GNAQ, RUNDC1, RAB3GAP2, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RAB3GAP1, EZH2, LIMS1]
GO:0055091;phospholipid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.57984905034425;0.0010826797251974863;0.738553198190834;[GPAM]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[TFRC, SLC22A17, MYC, NEDD8]
GO:0006637;acyl-CoA metabolic process;5.0;0.5902001590945054;0.5853410914081729;7.97986562690474;77.21017702370673;5.244474134527214;0.0025841551403354684;0.5584436629936305;[ACLY, ACOT7, GPAM, ELOVL5, ACSL6, HSD17B4, SUCLG1, ELOVL6, DBI, ACOT4, ACACA]
GO:0006635;fatty acid beta-oxidation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;579.9307786885206;5.734022359845919;0.019409761258888828;0.6894787953221185;[ECHS1, ACOX2, CPT2, HSD17B4, ETFA, ETFB, SLC27A2, HIBCH]
GO:0045292;mRNA cis splicing, via spliceosome;12.0;1.0;0.9481203125901445;9.628524252492122;357.76734256588776;6.444869117505266;0.011974150985975996;0.7777112189764279;[WBP4, DCPS]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, RXRA, ALDH5A1, IMPDH2, PPAT, ATPIF1, ALDOA, ACACA, GLS]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ERN1, XBP1, ENDOG, NME1]
GO:0043550;regulation of lipid kinase activity;9.0;0.7369933605727446;0.7647373054666613;9.292052015870908;63.107251229778875;5.825829909099042;0.0021121429058218954;0.694173837660411;[PDGFRB, RBL1, PIK3IP1, CCL19]
GO:0006518;peptide metabolic process;5.0;0.5557027117453593;0.5680923677336;7.651361559932704;56.97144087449193;3.860871565073034;0.001906782855101251;0.48768616324764424;[BECN1, HBS1L, RPL3, MRPS36, RRBP1, RPS15, NPEPPS, RPL36AL, LAMP2, CTSH, CHAC2, SEC11A, RPL19, SEC11C, RPL39L, GSTK1, RPS9, NDUFA7, MRPS24, RPS7, MRPS18B, MRPS18A, CTNS, LNPEP, RPL23A, RPL3L, TAPBP, SPCS2, COPS5, GSTA5, ALDH5A1, XPNPEP1, RPL7L1, TPP1, RPL22L1, RPL29, THOP1, CPEB4]
GO:0006639;acylglycerol metabolic process;6.0;0.7307253602413294;0.6884829927108091;8.986670366319727;83.80209709147016;5.277263957350204;0.0028047807726606097;0.5929998367869052;[AGPAT5, DGKD, FABP5, GPAM, DGKA, DAGLB, MGLL]
GO:0070126;mitochondrial translational termination;7.0;1.0;0.8509193652572005;9.628524252492122;40.68669918132259;5.277263957350204;0.0013617472059468932;0.6207988894539612;[MRPL40, MRPS24, MRPS36, MRPS22, MRPS18B, MRPS18A, MRPL17]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, ZNF175, APOBEC3F, DTX3L, APOBEC3H, DDX41, ZC3HAV1, TMEM173, LYST, UNC13D, RELA, ITCH, ILF3, IL6, GPAM, POLR3C, IL23A, POLR3E, DDIT4, NLRP3, SERINC3, APOBEC3A, EXOC1]
GO:0070127;tRNA aminoacylation for mitochondrial protein translation;11.0;0.7043150770688792;0.7845864908641018;9.074213516786392;322.595581717198;7.697632086000634;0.010796983802900059;0.8260862151842345;[EARS2]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[ENDOG, RORA, AQP3, SIRT2, AQP1, NPEPPS, SFRP1, CCNB1, TBL2, MYC, LMNA, UBQLN1, HYOU1, ATP7A, KCNK3]
GO:0070125;mitochondrial translational elongation;7.0;1.0;0.8509193652572005;9.628524252492122;106.95016378538953;5.299736813202263;0.0035795257329985885;0.6219481523473303;[MRPL40, MRPS24, MRPS36, MRPS22, MRPS18B, MRPS18A, MRPL17]
GO:0033578;protein glycosylation in Golgi;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;176.5615275388073;9.083926447120524;0.005909355431665436;0.839552420951524;[FUT8]
GO:0046949;fatty-acyl-CoA biosynthetic process;7.0;0.7866048967936545;0.7442218136540277;9.352270875863963;404.0761203118406;6.409777797693995;0.01352406410193885;0.6787156999164222;[ACLY, ELOVL5, ACSL6, ELOVL6, ACACA]
GO:0044528;regulation of mitochondrial mRNA stability;10.0;1.0;0.9152410118609203;9.628524252492122;284.1794570854127;8.390779266560578;0.009511230683741751;0.8443458537639685;[FASTKD1]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[PCNA, DTX3L, EYA2, TIMELESS, BRCA1]
GO:0090305;nucleic acid phosphodiester bond hydrolysis;6.0;0.6073376606709605;0.6267891429256247;8.355558576679234;112.24841944109592;4.100319825412187;0.0037568535816745637;0.5328108591460956;[DCLRE1A, FEN1, DCLRE1C, PCNA, POP4, PNKP, SMG5, WRN, PCF11, EXO1, EXOSC3, DCPS, RFC5, DFFA, RFC3, CPSF6, REXO1, RFC4, ENDOG, FBXO18, CPSF3, CPSF2, APEX2, RNASE3, GTF2H4, SND1, ERN1, DDB1, BOP1, CNOT6, PAN3, XRN1, LAS1L, CNOT1, RPP21, ERCC5, CNOT8, DCP1A, DCP2, KPNB1]
GO:0045616;regulation of keratinocyte differentiation;7.0;0.8259837884571596;0.7639112594857803;9.461470167828956;71.48722327515921;6.113511981550823;0.002392613028695569;0.663564652301091;[ERRFI1, ROCK2, GRHL1, AQP3]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNB1, CCNH, MNAT1, CKS1B]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BCLAF1, PCNA, FBXO18, DTX3L, EYA2, MYC, TIMELESS, BRCA1]
GO:0090303;positive regulation of wound healing;7.0;0.7043150770688792;0.7030769037916401;8.753055515138222;62.345319237194666;5.905872616772578;0.002086641727724376;0.6529459655301135;[XBP1, TBXA2R, THBS1, HRAS, HBEGF]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[CMTM7, DOCK11, DCLRE1C, SP3, BCL3, EP300, CARD11]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[OXTR, AHCYL1, SUCNR1, DGKD, ROCK2, DGKA, DEFB1, IQGAP2, CRHR1, RIC8A, HEBP1, C3, ABR, AKAP13, GPR132, GNG2, GNAT2, RGS1, TBXA2R, ADORA3, CCL5, NPPA, OR56B1, HOMER3, CCL19, ECT2, NTSR1, CCR2, PDGFRB, SLC12A2, SPHK2, CCL20, SPHK1, GPR55, TSHR, VAV1, SFRP1, GAL, GPR180, GNAQ, GNB2, NMUR1, CALM3, ARHGEF1, CALM1, DAGLB, CALM2, ARHGEF5]
GO:0014032;neural crest cell development;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;64.99956039719687;6.558197802812269;0.002175476790687691;0.6256275524841266;[NOLC1, SOX8, KLHL12]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[TBP, CSNK2A1, RPS7, SENP2, BOP1, NUAK1, TP53INP1, CDK2, TRIM24, TP53BP2, EP300, TAF7, RFFL]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[CARD11]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, PDCD1LG2, CORO1A, CD4, IL6, HLA-DMB, GPAM, IL23A, CCL5, HLA-DPB1, NCKAP1L, IL12A, CCL19, CARD11, CCR2, HLA-DPA1, HAVCR2]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[COLEC12, DGKD, CD163L1, TFRC, WIPF2, ITGB3, ITGB2, STON1, CLTA, FNBP1L, RABEPK, LRP8, CORO1A, TM9SF4, HSP90B1, CLN3, KIAA1109, HSPH1, AP2S1, APOL1, SCARF1, HRAS, FCER1G, AMBP, FNBP1, CDC7, UNC13D, MARCH3, NME1, RUFY1, GAK, SYNJ1, CDK5, SNX17, CD9, PIK3C3, HYOU1, DOCK2, CSNK1G2, CSNK1G1]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, FCER1G, CD163L1, TFRC, AMBP, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, HSP90B1, GAK, CLN3, HSPH1, SYNJ1, SNX17, AP2S1, CD9, HYOU1, APOL1, SCARF1]
GO:0046825;regulation of protein export from nucleus;8.0;0.7090535922965819;0.729526796148291;9.089527751759436;125.87245037263493;6.088194173566533;0.004212837636121377;0.6863505331661754;[CDK5, BAG3, TPR, XPO5, THOC2, CAMK1, SUPT6H, GTSE1]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[GPAM, IL23A]
GO:0006654;phosphatidic acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;659.6112576846374;6.139487467954083;0.022076595183113425;0.6889736746265369;[AGPAT5, PLA2G12A, GPAM, DGKA]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[UPF2, UPF1, SMG1, SEH1L, POLDIP3, CPSF3, CPSF2, EIF4A3, NUP153, THOC2, CASC3, SMG5, SRRM1, THOC6, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, NUP43, SLU7, RAE1]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[TBX1, GSTK1, CSTA, PCNA, HDAC1, ITGA2, VIL1, FZR1, RXRA, LBH, NFIB, CCM2, TPP1, E2F7, E2F8]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[XRCC5, PNKP, MYC]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[PDGFRB, CD4, SFRP1, OXTR, ENDOG, PCNA, ITGA2, EZH2]
GO:0070236;negative regulation of activation-induced cell death of T cells;11.0;1.0;0.9324289523296623;9.628524252492122;227.77452970025269;8.390779266560578;0.0076234085252994;0.8615337942327104;[TSC22D4, GPAM]
GO:0010107;potassium ion import;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;121.72212082045542;6.063501560976162;0.004073929841064025;0.7253287636709003;[SLC12A2, ATP1B2]
GO:0014029;neural crest formation;6.0;1.0;0.8231203125901445;9.628524252492122;35.87688261436843;7.8311634786251565;0.0012007669740048141;0.7236063770733796;[NOLC1, KLHL12]
GO:0010586;miRNA metabolic process;8.0;0.8653626801206646;0.8076813400603323;9.456673995565463;117.72069011476309;6.943860283624253;0.003940005556398338;0.7301093378270707;[XPO5]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, BRCA1, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, THOP1, HIST1H2BC, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, FZR1, RNF213, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, TSPAN17, KBTBD2, FBXL3, TRIM32, ASB3]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[TBCCD1, WDR1, EPB41, WIPF2, LST1, ITGB2, CDC7, VRK1, VRK2, CORO1A, VIL1, MKLN1, CFDP1, FES, TAOK2, ALDOA, CSNK1G2, CSNK1G1]
GO:0014002;astrocyte development;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.09911675737102;6.832634648514029;0.001141266750656509;0.639662265535933;[CDK6, TSPAN2, KRAS]
GO:0006065;UDP-glucuronate biosynthetic process;8.0;1.0;0.875;9.628524252492122;847.4108547704801;8.67846133901236;0.028362078688912176;0.8188169164668168;[UGDH]
GO:0006189;'de novo' IMP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6149.890129209738;7.9853141584524145;0.20583128808286652;0.8564896500084854;[PPAT]
GO:0046710;GDP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.574457031221845;1314.1926939491284;7.138016298065211;0.04398484676983994;0.7802794972956796;[CARD11, TJP2]
GO:0046037;GMP metabolic process;10.0;0.8259837884571596;0.8282329060895002;9.548481544818586;1315.1089846810005;6.7325511899570465;0.04401551419602758;0.7595439928109722;[IMPDH2, PDE6B, CARD11, TJP2]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[PCNA, CDK2, CDC7, HRAS, E2F7, E2F8]
GO:0042355;L-fucose catabolic process;8.0;1.0;0.875;9.628524252492122;210.4172434324934;7.57984905034425;0.007042475774460966;0.7626338329336335;[FUT8, FUT4]
GO:0048699;generation of neurons;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.474488534686424;7.282666309192915E-4;0.6724867031240476;[CDK6, THOC2, CIT]
GO:1903748;negative regulation of establishment of protein localization to mitochondrion;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;114.80715385295086;7.57984905034425;0.0038424921197278824;0.738553198190834;[HSPH1, BAG3]
GO:1904837;beta-catenin-TCF complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;6.409777797693995;0.0013529121422039536;0.618037346520142;[TLE4, CREBBP, HDAC1, RBBP5, MYC, EP300]
GO:1903507;negative regulation of nucleic acid-templated transcription;9.0;0.5547065974044363;0.6735939238825073;8.375761283996754;898.5514994986271;2.646975117554892;0.030073710044371104;0.5316070557889775;[ZNF175, NAB1, GFI1, GMNN, ARID4A, IKZF1, IKZF2, YY1, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, SFMBT2, ZBTB32, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, WFS1, NONO, H3F3A, NFKB1, CDK5, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, OTUD7B, BRCA1, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, DACT1, ZNF485, TSC22D4, HELLS, KLF12, PEG3, ARID1A, SIRT2, DUSP22, NCOR1, RBL1, TFDP2, NFX1, MTF2, TFEC, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, LIMS1]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[HERPUD2, HSPH1, RHBDD1, HSPA6, HSPB3, HSPE1, THBS1]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[BTG2, CDKN1A, PCNA, CNOT10, CNOT4, CNOT6, CCNB1, TFDP1, TFDP2, CNOT1, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN3, FBXL15, PKMYT1, MASTL, TUBG1, CKAP5, CDC25A, CIT, CCNB1, WEE1, PPME1, CENPJ, CEP70, CDK2, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[TFDP1, PCNA, TFDP2, CCNE1, GFI1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, CDKN2C, MAX, GMNN, MCM10, CDC7, CDC25A, POLE4, PPP6C, GPR132, WEE1, CDK6, CCNE2, CCNE1, POLE2, PPAT, MYC, CDK2, MCM5, MCM6, SKP2, MNAT1, MCM2]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CREBBP, CDKN1A, PCNA, RHBDD1, CDC25A, AQP1, YY1, DDB1, HIST3H2A, MYC, TP53INP1, PBK, EP300, PPID]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[RAD51AP1, NIPBL, SFRP1, CDKN1A, WRN, RAD51, XRCC5, INTS7, ECT2, ELK1, TANK, HRAS]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[KCNK6, CLIC5, AHCYL1, WDR1, KCNA3, THBS1, CORO1A, GPR89B, CRHR1, NPPA, UBQLN1, ARL6IP5, RIPK1, ATP7A, NTSR1, KCND1, KCNK12, CACNA2D3, OXSR1, ATP1B2, PER2, GAL, SLMAP, CALM3, FXYD5, CALM1, CALM2]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[OXTR, DGKD, MAML1, CCNH, DGKA, CD80, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA2, MYC, CFL1, TRIM24, NEK1, SEPHS1, PDGFRB, CSNK2A1, PAQR3, ZFYVE21, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, EPHA1, CSNK1G2, CSNK1G1, ATP5J, ATP5I, ATP5O, PKMYT1, RASGRP4, ATP5L, STK3, NUAK1, CCNB1, STK35, STK38, STK38L, MBP, RIPK1, CYC1, MARK2, EIF2AK3, DOLK, CDC7, ERLIN2, CLK4, CLK3, NFKB1, SETX, CLK1, CDK9, GNPTG, UCK2, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, CALM1, MNAT1, CIITA, SMG1, FASTKD1, MAST3, ADPGK, YWHAB, HK3, AKAP13, ZMYM2, PBK, CTSH, HRAS, DUSP5, TPI1, KSR1, SPHK2, SPHK1, CAD, BPGM, OXSR1, ATP5F1, MASTL, GFRA2, SPTB, COASY, VAV1, NME1, CIT, GAK, ITPKB, PDIK1L, IMPAD1, FASTKD5, PIK3C3, ALDOA, HBEGF, PRPS2, PDXK, ROCK2, PNKP, COX5B, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, GTF2H4, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1]
GO:2000059;negative regulation of ubiquitin-dependent protein catabolic process;10.0;0.8259837884571596;0.8282329060895002;9.510741216835738;1664.7506957432736;6.039404009397101;0.05571770760817117;0.7240964137624963;[PDCL3, RPS7, CLEC16A, PBK]
GO:0038202;TORC1 signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.12151398160788;7.697632086000634;9.077326651865194E-4;0.7445766281117727;[CLEC16A, CARD11]
GO:0006072;glycerol-3-phosphate metabolic process;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;73.92550031691772;7.474488534686424;0.0024742199669763555;0.7053660038532718;[GPAM]
GO:1903751;negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;11.0;0.9326813400603323;0.8987696223598284;9.607470843294289;1990.4228190328738;8.390779266560578;0.06661766048879188;0.8615337942327104;[HSPH1]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[SPAG6, STRBP, H3F3A, CIB1, AFF4, IQCG]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[GAK, TOR1A, HSPH1, DNAJC7, HSPA6, BAG1, HSPE1]
GO:1903753;negative regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1764.046878661414;8.16763571524637;0.0590410614896785;0.8658135829017477;[HSPH1, PTPN22]
GO:0043697;cell dedifferentiation;3.0;0.8653626801206646;0.6308016526504768;9.292052015870908;23.14253743147029;7.9853141584524145;7.745599008998212E-4;0.6064896500084854;[CDK6]
GO:1990481;mRNA pseudouridine synthesis;9.0;1.0;0.896240625180289;9.628524252492122;385.3348722779794;8.390779266560578;0.012896811396273711;0.8253454670833372;[PUS1]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[ACLY, XBP1, ACOT7, ELOVL5, DEGS1, ELOVL6, BRCA1, HSD17B8, PRKAB1, FADS1, MGLL, ACACA]
GO:0046605;regulation of centrosome cycle;8.0;0.7192862368539868;0.7346431184269935;9.193206181234276;52.95861036100919;5.69953618377475;0.0017724770291279795;0.6664745454937787;[NSFL1C, PDCD6IP, ROCK2, CENPJ, NUP62, CCNF, CHMP4B, BRCA1, MCPH1]
GO:0006631;fatty acid metabolic process;7.0;0.5408746917014966;0.6213567111079488;7.849668188099975;91.0232021896581;4.037280715501235;0.0030464646617242943;0.5573860888006872;[ECHS1, HSD17B4, ETFA, ETFB, BRCA1, HSD17B8, ADIPOR2, ACACA, C3, SGPL1, CPT2, FADS1, HIBCH, XBP1, ACOT7, ELOVL5, ACSL6, ELOVL6, PRKAB1, PER2, ALDH3A2, ACLY, ALDH5A1, ACOX2, GPAM, NDUFS6, DEGS1, DAGLB, SLC27A2, ACOT4, MGLL]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[CENPH, CENPK, CENPL, OIP5, CENPP, ITGB3BP]
GO:0070371;ERK1 and ERK2 cascade;10.0;1.0;0.9152410118609203;9.628524252492122;233.3964595037646;6.481236761676141;0.007811569456414605;0.7466917612613706;[OXTR, KARS, MYC, CTSH]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD4, IRF4, CD80, GLMN, CARD11]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, CCL20, FGG, GPR55, CIB1, PTPN22, IGF1R, RAP1B, CD4, KARS, CCL5, CCL19, EPHA1, HRAS, HAVCR2]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CCNF, BUB1B, UBE2Z, UBE2L3, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, MYC, LONP2, SKP2, C18orf25, RNF44, FBXO18, ARRDC1, TRPC4AP, KCTD5, CDC25A, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7A, ANAPC11, C2, HSP90B1, C3, VCPIP1, CCNB1, RHOT1, RNF213, UBD, NLRP3, USP51, RIPK1, AMZ2, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, LNPEP, ERLIN2, BTBD6, PGA3, PGA5, NFKB1, NFKBIA, NSFL1C, COPS5, RNF103, NPLOC4, FBXL3, TPP1, USP36, WDR48, PPP1R11, USP32, USP34, KIF14, OTUD7B, BRCA1, USP39, SENP6, POLB, TRIM9, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, SENP2, JOSD1, SIRT2, DDB1, PSMA1, ESPL1, PIK3C3, MAN1B1, USP41, THOP1, BECN1, DERL3, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, CLN3, FZR1, PSMB5, TP53INP2, PERP, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP2, PSMC1, TRIM32, C1QC, MAD2L1]
GO:0031124;mRNA 3'-end processing;9.0;0.8436909121759173;0.8180860812682478;9.52844079393514;355.1646528804444;5.407625775213448;0.011887041304472852;0.6727868588050205;[AHCYL1, CPSF6, POLDIP3, CPSF3, CPSF2, EIF4A3, SSU72, THOC2, CASC3, SRRM1, THOC6, PABPN1, PCF11, U2AF2, SLU7]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC12A2, SLC9A6, SLC20A1, PKD2L1, ATP1B2]
GO:0032211;negative regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1705.737369485817;6.781341354126479;0.05708949469272255;0.7620391240755716;[GNL3L, XRN1, NAT10, DCP2]
GO:2001295;malonyl-CoA biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;353.9588090559049;9.083926447120524;0.011846682796854502;0.8154717862087246;[ACACA]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[FANCI, TIPIN, ZWILCH, INTS3, DONSON, MAD2L1BP, BUB1B, BRCA1, ZWINT, CENPF, WEE1, TPR, TAOK2, CDK2, ZNF207, KNTC1, TOPBP1, HRAS, MAD2L1]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[RAB3B, AHCYL1, SYS1, RPL3, DGKD, TFRC, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, EIF4ENIF1, IPO8, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, VPS18, GSTK1, RPS9, RPS7, ARRDC1, VPS33A, COG4, VPS33B, COG3, AP1B1, COG1, TBC1D2B, MYO7A, SYTL3, BCR, RUFY1, RINT1, UNC50, CHMP4B, KIF20A, RPL29, SLC27A2, KPNB1, ACOT4, PPID, CARD11, COPB2, COPA, SUCNR1, VPS26B, ABCB9, HSP90B1, VPS8, VPS11, NLRP3, ECT2, RAB6A, ATP6V1F, VPS16, BBS2, XBP1, TOR1A, PMM1, VTA1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, HYOU1, ARF3, TRAM1, AHCTF1, SFT2D3, YWHAB, SRP54, CLTA, LYST, TRAM2, GPR89B, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, SNAP29, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, PDCD6IP, DTX3L, SSR2, RHBDF2, FGG, TBC1D8, BTN3A2, SENP2, ARFGAP1, AFTPH, GAL, ACOX2, AGPS, EXOC3, LCP2, CHMP6, SLU7, VAMP5, PAFAH1B1, EXOC1, SEC22C, RABGAP1, GOSR1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, RRBP1, NLRC4, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, SNX25, LMNA, VPS52, AP2S1, HEATR3, STX5, VPS54, CCL19, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, ARFGEF2, PEX19, SYVN1, RPL23A, RAB11A, ARCN1, CENPF, SPCS2, MCM3AP, SNX19, GPAM, SNX17, SNX14, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, APBA3, SEC24C]
GO:0034472;snRNA 3'-end processing;10.0;0.8259837884571596;0.8282329060895002;9.423729839846109;715.1711836533467;6.444869117505266;0.023936135904599073;0.7448319182472036;[INTS7, EXOSC3]
GO:0046579;positive regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;287.86983276338884;5.905872616772578;0.009634744236561129;0.6982672254532021;[PDGFRB, ITPKB, AKAP13, ALS2, GPR55, KRAS, HRAS, RASGRP4]
GO:0043069;negative regulation of programmed cell death;6.0;0.5470854108181258;0.5966630179992074;7.49501548954201;59.55619652718796;2.9592430562263194;0.001993292300667925;0.47445614010443393;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, BRCA1, AATF, UBE2Z, IGF1R, AQP1, MYC, NUP62, CFL1, CASP2, CTSH, SOX8, HRAS, IER3, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, THOC6, DDB1, ITPKB, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, CORO1A, RELA, MTDH, HSP90B1, UNG, CLN3, HSPH1, BAG3, CCL5, LMNA, BAG1, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, DCPS, NTSR1, TBX1, TFAP2A, PRELID1, XBP1, UBE2B, EYA2, WFS1, NONO, RHBDD1, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, GPAM, TNIP2, BCL3, KRAS, ERCC5, HYOU1, PDCD1, MNAT1, TRIM32, MAD2L1, CPEB4]
GO:0001302;replicative cell aging;4.0;1.0;0.75;9.628524252492122;26.138269705024182;8.16763571524637;8.748243641116619E-4;0.6676932703116032;[WRN]
GO:0043987;histone H3-S10 phosphorylation;11.0;0.9326813400603323;0.8987696223598284;9.59462270081644;711.4828594708514;7.9853141584524145;0.023812691013487215;0.8407982897480031;[RPS6KA4, CCNB1, VRK1]
GO:0045008;depyrimidination;12.0;1.0;0.9481203125901445;9.628524252492122;4176.25036176625;7.697632086000634;0.13977534122700555;0.8417775754447168;[SMUG1, UNG]
GO:0000463;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;360.17083382419077;7.57984905034425;0.0120545936753897;0.8200627852632958;[BOP1, RPL7L1]
GO:1900407;regulation of cellular response to oxidative stress;6.0;0.6519675769143192;0.6491041010473041;8.999915593069748;44.95674759120822;5.500407508664414;0.0015046618834316918;0.6044114083783503;[FUT8, ENDOG, HSPH1, NONO, UBQLN1, RIPK1, FBLN5]
GO:0008616;queuosine biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;1018.8444900108386;8.16763571524637;0.03409980818015198;0.8139338954918922;[PDCL3]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN1A, CDKN2C, EI24, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, CDK5, SERTAD2, NPPA]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[IL23A, BCL3, EBI3, HLA-DPB1, PTPN22, IL27, IL12A, HRAS, CD244, CCR2, HLA-DPA1, HAVCR2]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DUT, TXNRD1, NME1]
GO:0033137;negative regulation of peptidyl-serine phosphorylation;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;780.3281191277907;6.518977089658987;0.026116879897493853;0.7486218033895181;[DDIT4, PAQR3]
GO:0010259;multicellular organism aging;4.0;0.9326813400603323;0.7163406700301662;9.474373572664863;29.177677042081047;6.943860283624253;9.765505923939418E-4;0.6051093378270707;[WRN, NDUFS6]
GO:0070329;tRNA seleno-modification;11.0;1.0;0.9324289523296623;9.628524252492122;512.907165443018;9.083926447120524;0.017166541240897646;0.8969813732811862;[SEPHS1]
GO:0071539;protein localization to centrosome;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;37.378778991281564;6.781341354126479;0.0012510340941211122;0.7430387373949403;[GOLGB1, MCPH1]
GO:2000630;positive regulation of miRNA metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;378.4717563008913;8.16763571524637;0.012667109080923946;0.7926932703116032;[HRAS, NFKB1, RELA]
GO:0015840;urea transport;6.0;0.8933024483968273;0.7697715367885581;9.510741216835738;33.88215786904644;7.9853141584524145;0.001134005331914608;0.7314896500084853;[AQP3]
GO:0042306;regulation of protein import into nucleus;8.0;0.8259837884571596;0.7879918942285797;9.510741216835738;189.4811146876517;5.618190544320798;0.006341762386663705;0.6623145257091445;[CDKN1A, HDAC3, BAG3, PKIA, TPR, NUP62, NOLC1, ECT2, TMEM173]
GO:0090503;RNA phosphodiester bond hydrolysis, exonucleolytic;8.0;0.8436909121759173;0.7968454560879586;9.466005322994347;231.13671471601307;6.166155715036245;0.007735937832006836;0.6903374900225189;[CNOT6, PAN3, XRN1, CNOT1, CNOT8, EXOSC3, DCPS, DCP2]
GO:0055064;chloride ion homeostasis;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;35.39315814371355;7.212124270218933;0.0011845771512957555;0.7438283705770736;[SLC12A2, ABCC2]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[NCKAP1, TBCCD1, ITGB3, LST1, KIF14, THOC2, PARVG, VSIG1, TBC1D20, NCKAP1L, ECT2, EPHA1, SOX6]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[KCNK6, SLC23A2, CLIC5, SLC25A3, COX4I1, SLC35B1, ATP2A2, PKD2L1, COX6A1, BEST3, GPR89B, AQP1, CPT2, ARL6IP5, CLCC1, ATP7A, SLC30A7, SLC36A1, KCND1, SLC35C2, KCNK12, CACNA2D3, ZDHHC13, ATP1B2, ATP5F1, TRPC4AP, SLC39A14, SLC5A6, COX7A2L, SLC9A6, NDUFS7, VDAC3, VDAC2, SLC25A10, SLC20A1, KCNA3, ITPR2, ATP5J, ATP5I, SLC1A4, COX5B, ATP5O, CLCN3, ACACA, ATP5L, RHD, ANKH, SLC38A6, CYC1, SLC25A20, CCL19, APOL1, NTSR1, ATP6V1F, TIMM8B, SLC35A2, SLC12A2, SLC37A1, ATP13A1, P2RX4, FXYD5, CALM1, KCNK3]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, CRTC2, DGKD, ITLN1, KCNA3, PKD2L1, NLRC4, CLYBL, ACACA, GLS, SPAST, RXRA, RNF213, PPAT, RIPK1, ECT2, BID, VASP, POLQ, PDCD6IP, KCND1, FCER1G, TOR1A, ATPIF1, EIF2AK3, KCTD5, MARCKS, ALDH5A1, RAD51, P2RX4, KCTD10, IMPDH2, KCTD14, CHMP4B, ALDOA]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, HDAC3, TUBGCP2, CIB1, TUBA1C, CCNB1, TUBA1B, SPAST, KIF19, NUF2, LMNA, ZNF207, FBXO5, NEFH, CLASP1, MARK2, BBS2, UBE2B, TUBG1, CKAP5, IQCG, NDC80, RAB11A, NSFL1C, CENPE, NIN, WEE1, SON, NCOR1, ESPL1, CDK5, FES, KIF4A, CENPJ, TBCE, KIF2C, KIF20A, VAMP4, CALM1, MAPRE1, KPNB1, PAFAH1B1, SPC25, MCPH1]
GO:0051135;positive regulation of NK T cell activation;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;288.14718947343493;7.697632086000634;0.009644027116041537;0.8088982747154926;[HSPH1, IL23A, IL12A]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, TFRC, NCKAP1L, CARD11]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[CUEDC2, SUCNR1, CFH, OTUD7B, RORA, RELA, C2, IL22RA2, C3, ABR, NLRP7, C1QBP, CCL5, NPPA, PBK, NLRP3, A2M, CCR2, FCER1G, ITGA2, NFKB1, BCR, NFKBIA, NLRP12, IL6, KARS, IL23A, MGLL, C1QC, MCPH1]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[DCTN3, KIF14, BRCA1, GPR132, CCNB1, RAD21, CEP70, TOPBP1, CLASP1, FANCI, DONSON, CDC7, TUBG1, CKAP5, RAB11A, CDC25A, RINT1, CENPF, RAD51C, CDK6, PKIA, CENPJ, TAOK2, CDK2, MAPRE1, PAFAH1B1]
GO:0043406;positive regulation of MAP kinase activity;12.0;0.7043150770688792;0.8002778511245842;9.369013057007038;2605.6877929993507;4.201124524534153;0.08721002546492271;0.6629660161470909;[PDGFRB, MAP3K3, DUSP5, PDE6H, THBS1, MAPK8IP3, ERN1, AKAP13, KARS, TAOK2, DVL3, RIPK1, CSK, KRAS, CCL19, HRAS, ARHGEF5, EZH2]
GO:0043647;inositol phosphate metabolic process;6.0;0.7436939687323844;0.6949672969563367;9.280217558223907;87.6170970844922;5.769740442447999;0.002932465389149971;0.618185107137305;[ITPKB, MINPP1, SYNJ1, CALM1, NUDT3, NTSR1]
GO:0070902;mitochondrial tRNA pseudouridine synthesis;12.0;1.0;0.9481203125901445;9.628524252492122;2100.8241493702185;9.777073627680469;0.07031269366043616;0.9481203125901445;[PUS1]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PPP2CA, DUSP22, DUSP5, SFRP1, NUP62, STK38, PAQR3, PTPN22, DUSP14]
GO:0055075;potassium ion homeostasis;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;71.74727346628734;6.409777797693995;0.0024013166745626502;0.7027963346592216;[SLC12A2, ATP1B2]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB1, VRK1]
GO:0002181;cytoplasmic translation;8.0;1.0;0.875;9.628524252492122;403.65714686199146;5.825829909099042;0.013510041437624024;0.6729332124801218;[RPS7, RPL7L1, RPL22L1, RPL29, RPL19]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, COMT, FLCN, ADORA3, RPS6KA2, MYC, FNTB, NUP62, TRIM24, CTLA4, IL12A, HRAS, RBM5, HAVCR2, KLF13, IGFBP5, ATPIF1, EMP3, PDCD1LG2, SIRT2, NME1, SFRP1, TWSG1, GAL, TFDP1, KARS, TAX1BP3, B4GALT7, BECN1, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, CDKN2C, IDH2, GLMN, EAF2, IFT122, PER2, ITCH, IL6, CDK6, FAP, NFIB, CD9, MNDA, CNOT8, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, ITGB3, CD80, SIRPG, CCNF, KIF14, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, LBH, MYC, FNTB, CTSH, SOX8, IL12A, ATP7A, SKP2, HRAS, CCR2, HLA-DPA1, HAVCR2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, RUNX2, NME1, ERN1, SFRP1, CCNE2, IL23A, CCNE1, EPHA1, CARD11, HBEGF, HDAC1, FOXG1, EBI3, DERL2, NOLC1, CRIP2, THBS1, CORO1A, RELA, CCNB1, FZR1, HLA-DMB, CCL5, NCKAP1L, CCL19, TBX1, MAP3K3, XBP1, CDC7, TSHR, PDCL3, CNOT6, CD4, IL6, CDK6, GPAM, SP1, CDK2, HLA-DPB1, KRAS, FAM98A, CNOT8, MNAT1, CCNJL]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, NSMCE2, HRAS, ARNTL]
GO:0055078;sodium ion homeostasis;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;71.74727346628734;6.343086423195323;0.0024013166745626502;0.6993857346658935;[SLC12A2, ATP1B2]
GO:0042795;snRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1410.6487555617684;5.528578385631111;0.047213144347195396;0.730852068336507;[CDK9, ZNF143, TBP, ELL, POLR2B, SP1, INTS3, INTS10, INTS4, POLR2G, INTS7, GTF2E2]
GO:0051391;tRNA acetylation;11.0;1.0;0.9324289523296623;9.628524252492122;627.8281081304611;9.777073627680469;0.021012841770512682;0.9324289523296623;[NAT10]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[NDUFA7, NDUFB7, NDUFB10, NCF1, TXNRD1, COX4I1, NDUFA10, ETFA, ETFB, COX5B, COX6A1, UGDH, COX7A2L, ALDH5A1, NDUFS7, UQCRQ, NDUFS6, IDH3B, DEGS1, CYC1, BID]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[POLQ, DCLRE1A, DCLRE1C, XRCC5, BRCA1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, FLCN, NIPBL, HRAS, ZNF485, KLF13, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1]
GO:0006424;glutamyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;9.083926447120524;0.006875708083302461;0.8969813732811862;[EARS2]
GO:0006543;glutamine catabolic process;10.0;0.8653626801206646;0.8479223519212526;9.5544162803384;559.4129836827092;8.67846133901236;0.018723049124860988;0.8590579283277371;[PPAT, GLS]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[BBS2, VIL1, NIPBL, GPAM]
GO:0045943;positive regulation of transcription by RNA polymerase I;11.0;0.8653626801206646;0.8651102923899945;9.54628615425515;1461.5699037633856;6.686031174322154;0.04891742935144542;0.7743528975167437;[MARS, EIF2AK3, WDR43]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[CLN3, BTG2, WFS1, NONO, KIF14, KRAS, HYOU1, ADNP, SNCB, CORO1A, HRAS, CPEB4]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[MTPN, BTG2, EIF4E3, POLDIP3, EIF4A3, NOLC1, CASC3, THBS1, FXR1, EIF4ENIF1, ATXN2, RXRA, C1QBP, CCL5, TPR, MKNK2, POLR2G, UPF1, EIF5B, EIF2B4, RPS9, KLHL25, IGFBP5, YTHDF3, ITGA2, EIF2AK3, CNOT10, PER2, CNOT6, ILF3, IL6, XRN1, CNOT1, CAPRIN1, BCL3, CNOT3, ETF1, EIF4E2, CNOT8, EIF4G2, CPEB4]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[ERN1, PDGFRB, IL6, IGFBP5, ITGA2, CCL5, SKP2, MNAT1, THBS1, HBEGF]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[ERRFI1, NCF1, ITGB3, CD80, ITGB2, LRP8, IL22RA2, PPP2CA, PDCL3, CD4, SFRP1, IL6, HSPH1, IL23A, CCL5, IL12A, ADNP, CHMP6, HBEGF]
GO:0071435;potassium ion export;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;121.72212082045542;7.379178354882098;0.004073929841064025;0.7926125360964777;[KCNA3]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[MAP3K3, DUSP5, PDE6H, ITGB3, KIF14, ZFP91, TNFRSF10A, PILRB, OXSR1, THBS1, MAPK8IP3, STK3, ERN1, KARS, TAOK2, NEK1, NCKAP1L, RIPK1, ADNP, CCL19, ECT2, MARK2]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[CDK9, WRN, RAD51, PCNA, FBXO18]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, BTN2A1, PTPN22, BTN3A2, NFKB1, RELA, CD4, HLA-DPB1, LCP2, CSK, HLA-DRB3, HRAS, HLA-DQA1, CARD11, HLA-DPA1]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, GABARAPL1, CALCOCO2, VTA1, EI24, DYNLL2, PRKAB1, CLN3, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[MAP3K3, CDK6, RBL1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, WDR48, USP32, USP12, USP34, OTUD7B, NEDD8, BRCA1, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, TFPT, RHOT1, PSMD7, PSMB5, PSMD4, PSMD2, MYC, PSMB1, NLRP3, USP51, RIPK1, SKP2, USP46, RAD23A, JOSD1, CDC25A, NFKBIA, COPS5, PSMA1, TNIP2, PSMC1, PSME2, USP41]
GO:0007084;mitotic nuclear envelope reassembly;6.0;1.0;0.8231203125901445;9.628524252492122;35.641415366952565;7.8311634786251565;0.0011928860971405699;0.7236063770733796;[LMNA, VRK1]
GO:1902065;response to L-glutamate;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;96.09026658308662;7.474488534686424;0.0032160547469104574;0.7053660038532718;[PCNA]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD80, CTLA4, CSK, PDCD1, PDCD1LG2, CCL19, VAV1, CARD11]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[STX5, VRK1]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[CCNF, BRCA1, ANAPC11, UBE2L3, NPEPPS, FZR1, RNF213, CDC26, TRIM69, RFFL, SKP2, C18orf25, RNF20, UBE2B, DTX3L, SYVN1, ZFP91, FBXL15, LNPEP, FBXL16, ITCH, SPSB1, UBE2T, FBXL3, ANAPC5, TRIM32, THOP1]
GO:0055089;fatty acid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.138016298065211;0.0010826797251974863;0.7159578506919597;[XBP1, GPAM]
GO:0006310;DNA recombination;7.0;0.612588685250814;0.6572137078826075;8.529911963824013;149.0421272461911;4.488806596985934;0.0049883058697239;0.5804771433779154;[FEN1, WDR48, DCLRE1C, BRCA1, UNG, YY1, POLB, RAD51AP1, TFPT, NIPBL, WRN, EXO1, RAD21, RAD54L, EXOSC3, POLQ, ENDOG, FBXO18, NCOA6, XRCC5, NONO, GINS4, NSMCE2, APEX2, WRNIP1, CDC7, SETX, RAD51C, RAD51, MSH3]
GO:0045830;positive regulation of isotype switching;10.0;0.8259837884571596;0.8282329060895002;9.562926970006309;1202.2270179172035;6.686031174322154;0.04023745635561778;0.7571649570480019;[TFRC, EXOSC3, UNG]
GO:0000448;cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;468.0260020708524;9.083926447120524;0.01566440909325593;0.8969813732811862;[BOP1]
GO:0046368;GDP-L-fucose metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;147.32279532564462;8.390779266560578;0.0049307613776414785;0.7800242071602487;[FUT8]
GO:0009267;cellular response to starvation;6.0;0.6369964171292115;0.6416185211547503;8.460919092337061;112.76702064936369;4.807260328104469;0.0037742106974044997;0.5689638293298743;[BECN1, GABARAPL1, CDKN1A, XBP1, SEH1L, MAX, CLEC16A, EIF2AK3, COMT, SFRP1, WRN, TBL2, MARS, LAMP2, PIK3C3, FADS1, CPEB4]
GO:0006797;polyphosphate metabolic process;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;63.354664276645295;7.9853141584524145;0.0021204235978432287;0.6986103492792611;[MINPP1]
GO:1902504;regulation of signal transduction involved in mitotic G2 DNA damage checkpoint;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;189.119288336664;9.777073627680469;0.006329652384318721;0.896240625180289;[RINT1]
GO:0031848;protection from non-homologous end joining at telomere;9.0;1.0;0.896240625180289;9.628524252492122;217.09097804873235;7.8311634786251565;0.007265839666095271;0.7967266896635242;[DCLRE1A, DCLRE1C, TFIP11]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[MYC]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, DFFA, ENDOG, KPNB1]
GO:0048311;mitochondrion distribution;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;32.547621880228036;6.943860283624253;0.00108933961337327;0.6453503496879909;[MSTO1, TRAK1]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[ERRFI1, ABCC2, PCNA, DDIT4, AQP1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[PDGFRB, IL5RA, ERLIN2, CLK4, CLK3, IGF1R, CLK1, BCR, WEE1, ZMYM2, FES, TRIM24, NEK1, CSK, EPHA1, HBEGF]
GO:0003091;renal water homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;57.14336741787613;6.311337724880743;0.0019125370817844765;0.6736814700148209;[WFS1, AQP3, RAB11A, AQP1]
GO:0006361;transcription initiation from RNA polymerase I promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.311337724880743;0.015969835568764485;0.7190027299379095;[TBP, CCNH, TAF1A, POLR1E, MNAT1, GTF2H4]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[SLC12A2, CLIC5, SLC1A4, CLCC1, CLCN3, APOL1, BEST3]
GO:0006486;protein glycosylation;7.0;0.6181399273706679;0.6599893289425345;8.590536585640447;174.0766208890209;4.3090134865453384;0.005826187842367879;0.5712825153487487;[GALNT12, ST6GAL1, SDF2L1, PMM1, DERL3, SLC35C2, COG3, FUT11, RPN1, SYVN1, DOLK, ALG1, TRAK1, GALNT10, FUT4, DPM3, FUT8, DOLPP1, MGAT4B, STT3A, PGM3, MGAT3, MAN1B1, B4GALT7]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ZNF175, ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, BRCA1, ELK1, AFF4, MYC, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, MKL1, ZBTB32, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, RFX4, TFEC, MED20, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, HOXC4, POLR2G, HIVEP2, TFAP2A, POLR2J3, ZBTB17, ZNF143, XBP1, NFYC, INTS3, PBX3, EAF2, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, NFIA, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, INTS7, MNAT1, NFE2L1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[PDGFRB, MAP3K3, SMG1, CAD, EIF2AK3, VRK1, VRK2, CLK4, CLK3, IGF1R, CLK1, ERN1, BCR, CDK5, FES, CAMK4, MKNK2, TAOK2, TRIM24, RIPK1, CSK, EPHA1, MARK2, CSNK1G2]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[ST6GAL1, FUT8, PMM1, DERL3, DOLPP1, MGAT4B, RPN1, SYVN1, STT3A, PGM3, MGAT3, B4GALT7]
GO:0006363;termination of RNA polymerase I transcription;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.343086423195323;0.015969835568764485;0.7206263598461826;[TBP, CCNH, TAF1A, POLR1E, MNAT1, GTF2H4]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[RPS9, WDR37, RPS7, POP4, EIF4A3, NOLC1, NAT10, IMP4, WDR43, BYSL, RRP9, RPS15, BOP1, LAS1L, RPL7L1, MRTO4, EXOSC3]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[OXTR, YWHAB, IL5RA, RASGRP4, STK3, PABPN1, CCL5, MYC, CTSH, NEK1, NCAM1, MBP, RIPK1, HRAS, PDGFRB, MAP3K3, DUSP5, KSR1, PAQR3, OXSR1, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, CCM2, KRAS, CALM1, HBEGF]
GO:0002684;positive regulation of immune system process;4.0;0.40819069503113836;0.4540953475155692;5.712509225794438;22.60819230600372;2.833951204861041;7.566758504298466E-4;0.3949283964088022;[NCKAP1, TFRC, WIPF2, CD80, SIRPG, AQP3, NPPA, EP300, IL12A, LAG3, IL4R, FLT3LG, HLA-A, HLA-F, UNC13D, KARS, IL23A, PSPC1, ELMO1, CARD11, ANKRD17, CFH, EBI3, CD99L2, CORO1A, C2, HSP90B1, C3, HSPH1, NLRP3, NCKAP1L, RIPK1, HLA-DQA1, EIF2B4, CREBBP, XBP1, CADM1, BTN2A1, XRCC5, NONO, NFKB1, NFKBIA, IL6, ARPC2, FES, HLA-DRB3, CDKN1A, DOCK8, C12orf4, ITGB2, ARPC1A, PTPN22, AP1G1, C1QBP, CTLA4, HRAS, CCR2, HLA-DPA1, HAVCR2, FGA, ACTR2, FCER1G, ITGA2, FGG, ARNT, PDCD1LG2, BTN3A2, TMEM173, VAV1, ITPKB, CREB3, PIK3C3, LCP2, COLEC12, NLRC4, LILRA2, THBS1, TANK, RELA, UNG, HLA-DMB, CCL5, CSK, CCL19, EXOSC3, CCL20, ITCH, CD4, GPAM, POLR3C, TNIP2, HLA-DPB1, ACIN1, MNDA, KRAS, PDCD1, CD244, C1QC]
GO:0006488;dolichol-linked oligosaccharide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;80.91159753301743;7.069023426578259;0.00270803835371991;0.6846304993685643;[ALG9, ALG14, ALG1]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CREBBP, CDKN1A, TBP, MAML1, CCNH, RORA, ZNF45, GTF2H4, MED6, RUNX2, GTF2E2, CDK9, RXRA, POLR2B, NPPA, MED20, TAF7, POLR2G, MNAT1, GTF2I]
GO:0007214;gamma-aminobutyric acid signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.976932752798508;6.558197802812269;9.028936615729279E-4;0.6585068532133508;[SLC12A2]
GO:0006368;transcription elongation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;5.459585514144159;0.015969835568764485;0.675444082270312;[CDK9, ELL, POLR2B, CCNH, EAF2, POLR2G, MNAT1, SUPT6H, GTF2H4, AFF4]
GO:0006489;dolichyl diphosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;346.04394917679554;8.16763571524637;0.011581779559612143;0.7686126355688037;[DOLPP1, DOLK]
GO:0033617;mitochondrial respiratory chain complex IV assembly;8.0;1.0;0.875;9.628524252492122;93.05948570865222;6.832634648514029;0.003114617238568839;0.7244212536750128;[BCS1L]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[SETX, TBX1, PDGFRB, RXRA, SYNJ1, CTSH, AQP3, AQP1]
GO:0051684;maintenance of Golgi location;6.0;1.0;0.8231203125901445;9.628524252492122;40.05853332144524;8.67846133901236;0.001340723059929369;0.7669372290569613;[ARHGAP21, TBCCD1]
GO:0033979;box H/ACA snoRNA metabolic process;9.0;0.8653626801206646;0.8289219652406215;9.517298617381897;119.80013165644291;9.083926447120524;0.004009602593422474;0.8607930461318132;[NOLC1]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[ERN1, EIF2B4, XBP1, ENDOG, GPAM, THBS1, NME1]
GO:0098530;positive regulation of strand invasion;9.0;1.0;0.896240625180289;9.628524252492122;458.64352302068994;9.777073627680469;0.015350385963129928;0.896240625180289;[WRN]
GO:0010977;negative regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;494.1264199049594;4.793467005972133;0.016537966589312465;0.6413787507847162;[SEMA6B, GAK, CDK5, GFI1, RUFY3, PAQR3, CIB1, THOC2, LRIG2, PAFAH1B1, ZNF365]
GO:0046784;viral mRNA export from host cell nucleus;7.0;1.0;0.8509193652572005;9.628524252492122;39.0503986177502;7.697632086000634;0.001306981698659025;0.7445766281117727;[THOC2, THOC6]
GO:0016051;carbohydrate biosynthetic process;4.0;0.5159906454948852;0.5079953227474425;6.979314551412846;43.72038160071192;4.925043363760852;0.001463281826386932;0.5018669466606686;[PER2, CRTC2, FUT8, TPI1, G6PC3, CHST12, IMPAD1, GLT8D1, SLC25A10, BPGM, ALDOA]
GO:0042063;gliogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.9853141584524145;7.282666309192915E-4;0.6986103492792611;[CDK6]
GO:0048169;regulation of long-term neuronal synaptic plasticity;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;42.75619717690252;6.481236761676141;0.0014310114414316764;0.7276913745807394;[KRAS, HRAS, RAB11A]
GO:0071850;mitotic cell cycle arrest;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;120.3495477317274;7.069023426578259;0.00402799105501988;0.7124295520356204;[CDKN1A, FAP, MCPH1]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[PDE6D, TMED2, IQGAP2, HRAS]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, SEPT11, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, RFX4, CENPJ, TMEM107, NEK1, CCDC65, SNAP29, CLUAP1]
GO:0044806;G-quadruplex DNA unwinding;7.0;1.0;0.8509193652572005;9.628524252492122;23.726073882073138;7.8311634786251565;7.940903407527885E-4;0.7514054297404357;[WRN]
GO:0006491;N-glycan processing;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;96.66964063832829;6.832634648514029;0.0032354458751365986;0.6725415662651573;[GNPTG, FUT8, PRKCSH, EDEM1, MGAT4B, MAN1B1]
GO:0006370;7-methylguanosine mRNA capping;10.0;1.0;0.9152410118609203;9.628524252492122;354.47150569988446;6.250713103064308;0.011863842292131473;0.734902770639515;[POLR2B, CCNH, POLR2G, MNAT1, GTF2H4]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[SFRP1, XBP1, NCKAP1L, CARD11]
GO:0045333;cellular respiration;5.0;0.6799073451904818;0.6301946844561612;8.242229891372231;30.85741402911629;5.572381008289503;0.0010327698776848686;0.5752128357670632;[CHCHD5, NDUFS7, FASTKD1, COX4I1, FASTKD5, COX5B, COX6A1, COQ10B]
GO:0006011;UDP-glucose metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;147.32279532564462;8.16763571524637;0.0049307613776414785;0.7686126355688037;[UGDH]
GO:0000027;ribosomal large subunit assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;66.59596265062147;6.280566066213989;0.002228906937441061;0.6721078059595746;[BOP1, RPL3, MRTO4, RPL23A, RPL3L]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[DIABLO, EIF2AK3, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, MYC, ARL6IP5, NLRP3, CTSH, RIPK1, BID]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[PRELID1, XBP1, IL4R, CD80, IL27, ITPKB, IL23A, IRF4, CAMK4, NLRP3, CTLA4, NCKAP1L, IL12A, CCL19, CARD11]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[ZNF175, RPL3, RNH1, NAB1, GFI1, GMNN, EIF4A3, ARID4A, CASC3, IKZF1, IKZF2, UBE2Z, YY1, RPS15, EIF4ENIF1, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, DIP2A, SOX6, ZNF564, TLE4, RPS9, IGFBP5, RPS7, ZNF282, SLC35C2, SFMBT2, ZBTB32, SND1, RUNX2, ERN1, OLFM1, EID1, ILF3, SFRP1, BRMS1, ZNF93, XRN1, TBL1XR1, PSPC1, CCNE1, MRTO4, HOXB4, TIMELESS, ADNP, RPL29, PPID, MAX, FOXG1, SUPT6H, GLG1, MTDH, FXR1, CCNB1, NLRP7, BAG3, TPR, HIVEP1, HESX1, SUDS3, A2M, BPTF, BBS2, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, WFS1, NONO, H3F3A, EIF2AK3, CNOT10, LSM5, NFKB1, CDK9, CNOT4, CNOT6, PAN3, CDK5, CNOT1, PKIA, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, SKIV2L, CNOT8, DCP1A, EZH2, CPEB4, PHF19, CDKN1C, USP36, HBS1L, CIITA, BTG2, CDKN1A, SMG1, YWHAB, OTUD7B, PTPN22, BRCA1, SMG5, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, HRAS, DACT1, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, HELLS, KLF12, PEG3, ARID1A, SIRT2, NME1, DUSP22, NCOR1, RBL1, TFDP2, NFX1, PTRH2, MTF2, LCOR, ETF1, EIF4E2, DCP2, MCPH1, HDAC3, ZNF350, HDAC1, NLRC4, LRP8, THBS1, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, U2AF2, TP53INP1, POLR2G, EXOSC3, MTA2, DCPS, E2F7, ZNF189, RPL19, E2F8, IRX1, RNF20, YTHDF3, NFYC, RPL23A, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, LIMS1]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[ITCH, CREBBP, MAML1, PERP, MYC, NOTCH2NL, EP300, DTX2]
GO:0051452;intracellular pH reduction;11.0;0.811012628672052;0.8379352666656883;9.437469015729413;181.15151768737684;6.311337724880743;0.006062978271215114;0.7551910570872826;[CLN3, RAB20, CLCN3, GPR89B]
GO:0019432;triglyceride biosynthetic process;8.0;1.0;0.875;9.628524252492122;411.96489591296563;6.832634648514029;0.013788094321871398;0.7244212536750128;[GPAM]
GO:0032873;negative regulation of stress-activated MAPK cascade;11.0;0.8436909121759173;0.8542744084176208;9.56534535087059;1526.0559120613332;6.039404009397101;0.051075718015538125;0.7412843542312382;[ITCH, SFRP1, HDAC3, NCOR1, HSPH1, AMBP, MYC, PBK, PTPN22, PAFAH1B1, DACT1]
GO:0010863;positive regulation of phospholipase C activity;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;83.73920694943958;6.139487467954083;0.0028026758962042993;0.6889736746265369;[PDGFRB, GNAQ, GPR55, NMUR1, HRAS, RASGRP4]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[MCTP1, ONECUT2, DOCK8, ITGB3, KIF14, CIB1, IGF1R, FLCN, NIPBL, ADORA3, C1QBP, ARHGDIB, CTSH, IL12A, ATP7A, GTSE1, HRAS, CCR2, SEMA6B, PDGFRB, TBCCD1, IGFBP5, ITGA2, SPHK1, PTP4A1, BCR, NISCH, CREB3, SFRP1, KARS, IL23A, RUFY3, EPHA1, MAPRE1, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, ABR, RRAS, TBXA2R, CCL5, TP53INP1, LMNA, NCKAP1L, LRIG2, CCL19, RFFL, MTA2, CLASP1, RNF20, MAP3K3, STARD13, XBP1, CCL20, IDH2, RAB11A, VIL1, IL6, P2RX4, CDK5, SP1, TRIM32]
GO:0070634;transepithelial ammonium transport;7.0;1.0;0.8509193652572005;9.628524252492122;45.514515802263766;8.67846133901236;0.001523329883496921;0.7947362817240173;[SLC12A2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CD151, ONECUT2, ROCK2, DOCK8, ITGB3, CIB1, CD99L2, THBS1, CORO1A, IGF1R, NIPBL, C1QBP, CCL5, CTSH, NCKAP1L, IL12A, CCL19, ATP7A, GTSE1, HRAS, CLASP1, CCR2, SEMA6B, PDGFRB, MAP3K3, XBP1, IGFBP5, CCL20, ITGA2, SPHK1, RAB11A, PTP4A1, VIL1, CREB3, IL6, P2RX4, KARS, SP1, IL23A, RUFY3, EPHA1, MAPRE1, TRIM32, HBEGF]
GO:0019538;protein metabolic process;4.0;0.31436784026285136;0.4071839201314257;4.906206153130031;44.767102947536216;1.4356634162186042;0.0014983146478770883;0.3234198938705959;[ISCA2, OXTR, RPL3, MAML1, CCNH, CCNF, ZDHHC5, ZDHHC6, UBE2L3, PSMD8, RPS6KA4, RPS15, HERC4, PSMD7, HERC1, PSMD4, RPL36AL, RPS6KA2, PSMD2, CDC26, MYC, TRIM24, LONP2, SKP2, SEPHS1, ST6GAL1, CSNK2A1, ARRDC1, SLC35C2, COG3, NSMCE2, PAQR3, MRPS18B, MRPS18A, ALG1, PRKAB1, BCR, SFRP1, KARS, KCTD10, PSME2, EPHA1, RPL29, CFH, CDCA3, FUT11, RPN1, COPS7A, ANAPC11, C2, C3, TGOLN2, NUAK1, RHOT1, RNF213, HLTF, STK38L, AMZ2, A2M, RPL39L, CREBBP, XBP1, PMM1, SETDB1, ABCA3, EDEM1, H3F3A, EIF2AK3, LNPEP, CDC7, ERLIN2, PGA3, RPL3L, PGA5, SETX, GNPTG, RNF103, NPLOC4, KLHDC8A, CALU, FBXL3, CALM1, EZH2, CPEB4, PIGS, HBS1L, BTG2, SMG1, WDR48, PIGT, SETD3, PPP1R11, FASTKD1, GPAA1, SERPINA10, KIF14, CLTA, OTUD7B, BRCA1, TRIM9, AKAP13, UBL5, ZMYM2, TRIM7, C1QBP, PBK, CTSH, CTSE, HRAS, PCMTD1, VKORC1, DUSP5, SEC13, MRPS24, PARP2, JOSD1, GFRA2, SIRT2, CIT, DDB1, GAK, ITPKB, PSMA1, PDIK1L, MED20, FASTKD5, HBEGF, CSTA, PCNA, MRPS36, DERL3, ZDHHC23, ZDHHC24, DERL2, NEDD8, TRAK1, TANK, PSMA7, RELA, ARNTL, PPP2CA, EXTL2, GGA3, PSMB5, PERP, PSMB1, ADAM23, AP2S1, MGAT3, APOL1, RPL19, UBL4A, MAP3K3, EGLN2, LRRC29, SYVN1, DOHH, GTF2H4, RAB11A, PER2, KBTBD4, ITCH, SPSB1, SPCS2, FAP, CAMK4, PSMC1, KBTBD2, TAOK2, RPL22L1, CAMK1, C1QC, MAD2L1, RAB3B, GALNT12, CRTC2, ARID4A, IL5RA, BUB1B, STK19, UBE2Z, GALNT10, IGF1R, YY1, PPP1CB, PPP1CC, NPEPPS, PPME1, FNTB, NPPA, LAMP2, CFL1, EP300, NEK1, TGM6, C18orf25, PDGFRB, RPS9, RNF44, FBXO18, IGFBP5, RPS7, VPS33B, SSU72, VRK1, VRK2, TRPC4AP, KCTD5, CDC25A, PIAS2, ERN1, MINPP1, DPM3, ILF3, BRMS1, TBL1XR1, CCNE1, RPL7L1, CHMP4B, ANAPC5, PPID, CSNK1G2, HIST1H2BC, CSNK1G1, UBR4, DTX2, KLHL12, PKMYT1, RLF, RASGRP4, FUT4, ACACA, STK3, HSP90B1, VCPIP1, CCNB1, FUT8, STK35, UBD, STK38, NLRP3, USP51, MBP, RIPK1, CYTL1, SUDS3, RAB6A, MARK2, DR1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, AMBP, WFS1, RHBDD1, DOLK, BTBD6, CLK4, SSH3, CLK3, NFKB1, MARCH3, CLK1, CDK9, NFKBIA, CNOT4, NSFL1C, IL6, PAN3, COPS5, CDK6, CDK5, PTPRA, MAN2B2, FES, UBE2T, CDK2, STT3A, TPP1, MAN2B1, MNAT1, USP36, PRKCSH, MAST3, USP32, YWHAB, USP34, PTPN22, USP39, MSLN, DUSP14, SENP6, POLB, PPP6C, SUMO3, PGM3, CASP2, TRIM69, HIF1AN, ATP7A, USP46, FGA, PDCD6IP, KSR1, DTX3L, RHBDF2, FGG, CAD, ZFP91, DUSP28, RAD23A, PPP2R5D, OXSR1, SENP2, MASTL, SPTB, PTP4A1, DUSP22, DUSP23, ESPL1, IRF4, CTDSP2, PIK3C3, ETF1, MAN1B1, USP41, B4GALT7, THOP1, BECN1, HDAC3, HIST1H2BO, ITIH2, HIST1H2BJ, HDAC1, ROCK2, MGRN1, RNF38, USP12, RRBP1, NLRC4, LRP8, THBS1, PARL, PSMB10, PPM1G, TFPT, CLN3, FZR1, PABPN1, RBBP5, TP53INP2, CCL5, MKNK2, UBQLN1, NCAM1, CSK, RFFL, MTA2, SEC11A, SEC11C, RNF20, NDUFA7, EYA2, FEM1B, FBXL15, RPL23A, FBXL16, POLE4, CAPN13, SNRK, WEE1, XPNPEP1, TNIP2, DOLPP1, TSPAN17, RAB13, MGAT4B, CCM2, KRAS, FAM98A, TRIM32, ASB3]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[CD4, SFRP1, AQP3]
GO:0032077;positive regulation of deoxyribonuclease activity;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;813.6405734422207;8.16763571524637;0.027231817764135358;0.7926932703116032;[PCNA]
GO:0006464;cellular protein modification process;6.0;0.33881133730344803;0.4925259812418685;5.842712558201993;147.0276183392271;1.7630686329010112;0.004920882069548126;0.41328372446777834;[OXTR, MAML1, CCNH, CCNF, ZDHHC5, ZDHHC6, UBE2L3, PSMD8, RPS6KA4, HERC4, PSMD7, HERC1, PSMD4, RPS6KA2, PSMD2, CDC26, MYC, TRIM24, SKP2, SEPHS1, ST6GAL1, CSNK2A1, ARRDC1, SLC35C2, COG3, NSMCE2, PAQR3, ALG1, PRKAB1, BCR, KARS, KCTD10, PSME2, EPHA1, CDCA3, FUT11, RPN1, COPS7A, ANAPC11, C3, TGOLN2, NUAK1, RHOT1, RNF213, HLTF, STK38L, CREBBP, PMM1, SETDB1, EDEM1, EIF2AK3, LNPEP, CDC7, ERLIN2, SETX, RNF103, KLHDC8A, CALU, FBXL3, CALM1, EZH2, PIGS, BTG2, SMG1, WDR48, PIGT, SETD3, PPP1R11, FASTKD1, GPAA1, SERPINA10, OTUD7B, BRCA1, TRIM9, AKAP13, UBL5, ZMYM2, TRIM7, PBK, CTSH, HRAS, PCMTD1, VKORC1, DUSP5, PARP2, JOSD1, GFRA2, SIRT2, CIT, DDB1, GAK, ITPKB, PSMA1, PDIK1L, MED20, FASTKD5, HBEGF, CSTA, PCNA, DERL3, ZDHHC23, ZDHHC24, DERL2, NEDD8, TRAK1, PSMA7, PPP2CA, PSMB5, PSMB1, MGAT3, APOL1, UBL4A, MAP3K3, EGLN2, SYVN1, DOHH, GTF2H4, RAB11A, PER2, ITCH, SPSB1, CAMK4, PSMC1, KBTBD2, TAOK2, CAMK1, RAB3B, GALNT12, CRTC2, ARID4A, IL5RA, BUB1B, STK19, UBE2Z, GALNT10, IGF1R, YY1, PPP1CB, PPP1CC, NPEPPS, PPME1, FNTB, CFL1, EP300, NEK1, TGM6, C18orf25, PDGFRB, RNF44, FBXO18, IGFBP5, VPS33B, SSU72, VRK1, VRK2, TRPC4AP, CDC25A, PIAS2, ERN1, MINPP1, DPM3, ILF3, BRMS1, TBL1XR1, CCNE1, ANAPC5, PPID, CSNK1G2, HIST1H2BC, CSNK1G1, UBR4, DTX2, KLHL12, PKMYT1, RLF, RASGRP4, FUT4, STK3, HSP90B1, VCPIP1, CCNB1, FUT8, STK35, UBD, STK38, NLRP3, USP51, MBP, RIPK1, SUDS3, RAB6A, MARK2, DR1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, AMBP, WFS1, RHBDD1, DOLK, BTBD6, CLK4, SSH3, CLK3, NFKB1, MARCH3, CLK1, CDK9, NFKBIA, CNOT4, IL6, PAN3, COPS5, CDK6, CDK5, PTPRA, MAN2B2, FES, UBE2T, CDK2, STT3A, MAN2B1, MNAT1, USP36, PRKCSH, MAST3, USP32, YWHAB, USP34, PTPN22, USP39, MSLN, DUSP14, SENP6, POLB, PPP6C, SUMO3, PGM3, TRIM69, HIF1AN, ATP7A, USP46, FGA, KSR1, DTX3L, FGG, CAD, ZFP91, DUSP28, RAD23A, PPP2R5D, OXSR1, SENP2, MASTL, SPTB, PTP4A1, DUSP22, DUSP23, IRF4, CTDSP2, PIK3C3, ETF1, MAN1B1, USP41, B4GALT7, THOP1, BECN1, HDAC3, HIST1H2BO, ITIH2, HIST1H2BJ, HDAC1, ROCK2, MGRN1, RNF38, USP12, NLRC4, THBS1, PSMB10, PPM1G, TFPT, FZR1, PABPN1, RBBP5, CCL5, MKNK2, NCAM1, CSK, RFFL, MTA2, RNF20, EYA2, FEM1B, FBXL15, FBXL16, POLE4, SNRK, WEE1, TNIP2, DOLPP1, TSPAN17, RAB13, MGAT4B, CCM2, KRAS, FAM98A, TRIM32, ASB3]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[NFX1]
GO:0045345;positive regulation of MHC class I biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[CIITA, NLRP12, HSPH1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, SMG1, FASTKD1, MAST3, MAML1, CCNH, YWHAB, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, AKAP13, ZMYM2, RPS6KA2, MYC, CFL1, TRIM24, PBK, CTSH, NEK1, HRAS, PDGFRB, DUSP5, CSNK2A1, KSR1, CAD, PAQR3, VRK1, VRK2, OXSR1, MASTL, GFRA2, SPTB, PRKAB1, CIT, ERN1, BCR, GAK, ITPKB, ILF3, KARS, PDIK1L, CCNE1, FASTKD5, PIK3C3, EPHA1, CSNK1G2, HBEGF, CSNK1G1, ROCK2, PKMYT1, RASGRP4, STK3, NUAK1, CCNB1, PABPN1, STK35, CCL5, STK38, MKNK2, STK38L, NCAM1, MBP, RIPK1, CSK, MARK2, MAP3K3, EIF2AK3, CDC7, ERLIN2, CLK4, GTF2H4, CLK3, NFKB1, SETX, CLK1, CDK9, SNRK, WEE1, PAN3, CDK6, CDK5, PTPRA, FES, TNIP2, CAMK4, TAOK2, CDK2, CCM2, KRAS, CAMK1, CALM1, MNAT1]
GO:0009615;response to virus;5.0;0.7436939687323844;0.6620879962271125;8.801845679307654;27.267803904038782;4.174954806800768;9.126288572378991E-4;0.503748394835965;[BECN1, ZNF175, DDX41, ZC3HAV1, LYST, RELA, CCL5, CFL1, NLRP3, IL12A, CCL19, IFNAR2, APOBEC3F, DTX3L, APOBEC3H, TMEM173, UNC13D, ITCH, ILF3, IL6, CDK6, GPAM, POLR3C, IL23A, BCL3, POLR3E, DDIT4, SERINC3, APOBEC3A, EXOC1]
GO:0006226;dUMP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6271.9915988638395;8.16763571524637;0.2099179143880009;0.8658135829017477;[DUT]
GO:0060623;regulation of chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.377209824211215;21.750886949199476;8.390779266560578;7.279826116623381E-4;0.7800242071602487;[CCNB1, H3F3A, MCPH1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, ZNF175, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, MYC, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, SOX6, ZNF564, DACT1, TLE4, KLF12, PEG3, ZBTB32, ARID1A, SIRT2, DUSP22, EID1, BRMS1, NCOR1, RBL1, TBL1XR1, CCNE1, NFX1, MTF2, HOXB4, TIMELESS, LCOR, PPID, MCPH1, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, BPTF, IRX1, TFAP2A, DR1, CREBBP, UBE2I, WFS1, NFKB1, PER2, GFI1B, NFIA, CNOT1, NFIB, NFIC, PKIA, SP3, CDK2, NFE2L3, TAF7, EZH2]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[ERRFI1, XBP1, SP1, MARS, PPAT, RAB13, RAB8B]
GO:0030206;chondroitin sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;416.1007025877491;6.558197802812269;0.013926516049292044;0.7103865406232063;[CHPF, CHST12]
GO:0051345;positive regulation of hydrolase activity;5.0;0.5651597194614189;0.5728208715916296;7.415551318187763;32.99397842971059;3.161008442547652;0.0011042787653896369;0.4518951306147327;[ERRFI1, DOCK8, BBC3, DOCK11, RGS1, MYC, ARHGDIB, ARL6IP5, CTSH, EVI5L, TBC1D22A, HRAS, PDGFRB, SEC13, ITGA2, TBC1D8, TBC1D2B, ATP1B2, DYNLL2, VAV1, ARFGAP1, BCR, MYL4, DEPDC1B, SFRP1, KARS, ALS2, DNAJC7, TBC1D20, MSH3, DNAJB11, PSME2, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RABGAP1, PCNA, DIABLO, ROCK2, NLRC4, RASGRP2, TANK, RASGRP4, RIC8A, ABR, ARHGAP21, WRN, CCL5, PERP, DVL3, NLRP3, MBP, NCKAP1L, RIPK1, CCL19, ECT2, A2M, BID, STARD13, PRELID1, CCL20, GPR55, EIF2AK3, TNFRSF10A, HSPE1, ARHGAP25, NLRP12, GNAQ, RUNDC1, RAB3GAP2, NMUR1, CALM3, CALM1, CALM2, RAB3GAP1, EZH2, LIMS1]
GO:0030208;dermatan sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;665.197598747091;7.292166977892469;0.022263564991093197;0.747921758369865;[CHST12]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[NFKBIA, PCNA, RPL19, EZH2]
GO:0031658;negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle;13.0;1.0;0.9625549647676366;9.628524252492122;3330.314475181895;7.8311634786251565;0.11146262839589782;0.8630410292508717;[CDKN2C, CDK6]
GO:0060628;regulation of ER to Golgi vesicle-mediated transport;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;59.76207228951576;7.004484905440688;0.0020001827771568793;0.6813299963962409;[RINT1, TBC1D20]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[SETX, WRN, RAD51, FBXO18, XRCC5, GINS4, ASCC3, MCM6, CHD1, GTF2H4, MCM2]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[SFRP1, UBE2B, MYC, DVL3, SDC1]
GO:0030321;transepithelial chloride transport;8.0;1.0;0.875;9.628524252492122;29.941547406775403;8.16763571524637;0.001002116646061566;0.7926932703116032;[SLC12A2]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFA11, NDUFB10, NDUFS7, NDUFS6, NUBPL, NDUFA10, BCS1L, FOXRED1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[SETX, BECN1, IL6, PCNA, ECT2, RELA, EZH2, AQP1]
GO:0032986;protein-DNA complex disassembly;5.0;0.8259837884571596;0.7032329060895001;9.223059144383958;56.94848366301809;6.7325511899570465;0.0019060144978933703;0.6345439928109722;[SMARCD2, HIST3H2A, MYC, ARID1A]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[DDB1, RFC5, RFC3, WDR48, RFC4, PCNA, UBE2B, PNKP, NEK1]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[BECN1, ERRFI1, PCNA, TFRC, ITPR2, PTPN22, BRCA1, RELA, HSP90B1, AQP1, EFTUD2, RAP1B, PPAT, MYC, TP53INP1, ECT2, DCPS, ABCC2, CAD, NFKB1, NME1, SETX, SFRP1, IL6, RAD51, P2RX4, XRN1, DDIT4, CDK2, TIMELESS, EZH2]
GO:0031098;stress-activated protein kinase signaling cascade;6.0;0.7980440201809971;0.722142322680643;9.193206181234276;55.4262366053078;5.142344639450834;0.0018550662588052154;0.5861000565951415;[MAP3K3, TNIP2, TAOK2, NEK1, CCM2, OXSR1, NFKB1, STK3]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[ZNF175, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, INTS10, ATF7IP2, HOXC13, BRCA1, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR1, NFX1, TFEC, MED20, VGLL4, ZNF350, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, CRTC2, NAB1, ARID4A, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZBTB32, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, PHF19, CIITA, ONECUT2, CHD1, AFF4, LBH, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, KLF12, TBP, KLF13, BUD31, MKL1, ARNT, SAFB, ARID1A, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3C, TNIP2, POLR3E, TAF7, MNDA]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[DUSP5, EYA2, SSU72, DUSP28, PTPN22, PPP2R5D, SSH3, CDC25A, PPM1G, DUSP14, PPP1CB, PTP4A1, PPP2CA, DUSP22, PPP1CC, DUSP23, PPP6C, MINPP1, PTPRA, CTDSP2]
GO:0050707;regulation of cytokine secretion;8.0;0.5887823193610073;0.6693911596805037;8.358061706897352;114.42085987655861;4.647174912757396;0.003829563207980042;0.6126567411541474;[XBP1, IL4R, PPP1R11, CADM1, GLMN, PTPN22, NLRP12, KARS, GPAM, NLRP7, NLRP3, MBP, CCL19, CD244, HAVCR2]
GO:0006112;energy reserve metabolic process;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;30.85741402911629;5.618190544320798;0.0010327698776848686;0.5775555375700647;[PPP1CB, PER2, PPP1CC, PYGB, MYC]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[ZNF175, MAML1, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, TIAL1, RPS6KA4, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SFMBT2, FLT3LG, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, KARS, IL23A, EWSR1, RFX4, BOLA3, HOXB4, TRIM14, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, SETDB1, ZNF260, XRCC5, H3F3A, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SOX30, SETX, STAG1, GOLGB1, PKIA, ZNF30, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, ATF7IP2, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, HRAS, HAVCR2, ZNF485, TSC22D4, HELLS, SEC13, NCOA6, SPHK1, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, VAV1, MED28, TOX4, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, VGLL4, ARHGEF5, ZNF350, PCNA, NEDD8, TRAK1, ZNF69, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, SERTAD2, UBN1, GPBP1L1, SCAND1, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, CAMK4, MARS, PSMC1, CAMK1, ZNF696, LIMS1, CRTC2, NCF1, NAB1, CD80, GMNN, ARID4A, CIB1, RORA, YY1, ADORA3, WWC3, ZNF207, EP300, SNIP1, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, SSU72, ZBTB32, PIAS2, ERN1, ARMCX3, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, CARD11, ZNF550, MAX, RLF, SUPT6H, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, UBE2I, WFS1, NONO, CNOT10, NFKB1, CDK9, NFKBIA, CNOT6, IRAK1BP1, IL6, TFCP2, COPS5, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, CNOT8, MNAT1, ZNF532, ZNF410, NFE2L1, PHF19, USP36, CIITA, ONECUT2, YWHAB, ITGB2, DDX41, CHD1, AFF4, CKS1B, FLCN, LBH, ZNF407, NUP62, GATAD1, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, DACT1, KLF12, TBP, KLF13, PEG3, DTX3L, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, MCPH1, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, NLRC4, LRP8, TFPT, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, ASCC3, ZNF622, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, RNF20, CHURC1, EYA2, FBXL15, ARID3B, DEK, USF2, CD4, POLR3C, TNIP2, TAF7, MNDA, KRAS, TRIM32]
GO:0000921;septin ring assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.16030555582066;7.069023426578259;0.003586558988939603;0.7124295520356204;[SEPT11]
GO:0061820;telomeric D-loop disassembly;9.0;1.0;0.896240625180289;9.628524252492122;185.09737597092234;7.697632086000634;0.00619504259692348;0.7898978880348613;[WRN]
GO:0000132;establishment of mitotic spindle orientation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;227.84740072539455;6.641579411751319;0.007625847452931234;0.7146506799819907;[NSFL1C, NDC80, PAFAH1B1, MCPH1]
GO:0016260;selenocysteine biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;562.4022950658948;9.083926447120524;0.01882309868665063;0.8797934328124444;[SEPHS1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, BRCA1, AATF, UBE2Z, IGF1R, AQP1, MYC, NUP62, CFL1, CASP2, CTSH, SOX8, HRAS, IER3, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, THOC6, DDB1, ITPKB, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, CORO1A, RELA, MTDH, HSP90B1, UNG, CLN3, HSPH1, BAG3, CCL5, LMNA, BAG1, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, PRELID1, XBP1, UBE2B, EYA2, WFS1, NONO, RHBDD1, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, GPAM, TNIP2, BCL3, KRAS, ERCC5, HYOU1, PDCD1, MNAT1, TRIM32, MAD2L1, CPEB4]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[ERN1, DUSP22, NCF1, TAOK2, DVL3, RIPK1, ZNF622, CCL19, MAPK8IP3, HRAS, ARHGEF5, STK3]
GO:0033146;regulation of intracellular estrogen receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;43.64299748026755;6.088194173566533;0.0014606918495168463;0.6622698984233759;[LBH, GPAM, CNOT1, WBP2, CRIPAK, BRCA1, SKP2]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[GALNT12, ST6GAL1, GALNT10]
GO:0016024;CDP-diacylglycerol biosynthetic process;8.0;1.0;0.875;9.628524252492122;660.3044048651973;7.212124270218933;0.0220997941954548;0.7438283705770736;[AGPAT5, GPAM]
